Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	155	"ductus deferens: 265.6;seminal vesicle: 360.6"	"Group enriched"	"Detected in some"	9	"RT4: 1.6;SK-BR-3: 4.5"	"Group enriched"	"Detected in some"	31	"breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058960	Approved									"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950741-49958881	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;EFO-21: 7.7;HEL: 2.2;HMC-1: 4.7;REH: 1.2"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced									"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.1	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	178.6	0.0	0.1	3.3	0.1	0.1	0.0	0.6	0.1	0.1	96.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.2	108.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PATE1	PATE	ENSG00000171053	"Prostate and testis expressed 1"	Q8WXA2	11	125746293-125749867	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"ductus deferens: 426.3;epididymis: 222.7;seminal vesicle: 185.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;NB-4: 6.4;RPMI-8226: 1.6;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076587	Approved				"Secreted in male reproductive system"					"HPA076587: AB_2732316"																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.3	0.2	0.0	426.3	0.0	0.2	222.7	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	10.0	0.0	0.0	0.2	185.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.0	0.2	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
SEMG1	"CT103, SEMG"	ENSG00000124233	"Semenogelin I"	P04279	20	45206997-45209772	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"ductus deferens: 2077.7;seminal vesicle: 1931.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;NB-4: 1.7;NTERA-2: 3.3;THP-1: 7.7"	"Cancer enriched"	"Detected in some"	14	"prostate cancer: 20.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	192	"eosinophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"									"HPA042476, HPA064892"	Enhanced				"Secreted in male reproductive system"	1700000	1700000			"HPA042476: AB_10794799, HPA064892: AB_2732724"			"unprognostic (3.71e-1)"								"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"		"unprognostic (3.32e-1)"			"unprognostic (1.11e-2)"	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	2077.7	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	76.5	0.0	0.0	0.2	1931.9	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	19.5	0.1	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PATE4	"FLJ41047, PATE-B"	ENSG00000237353	"Prostate and testis expressed 4"	P0C8F1	11	125833316-125840069	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"ductus deferens: 194.5;seminal vesicle: 232.9"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA045632	Approved				"Secreted in male reproductive system"					"HPA045632: AB_10960489"	"unprognostic (4.90e-1)"									"unprognostic (2.93e-2)"		"unprognostic (1.03e-1)"		"unprognostic (1.91e-1)"				0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.1	0.0	194.5	0.0	0.1	7.3	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.1	232.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	2.1	0.2	1.6	1.5	1.2	0.6	0.6	0.9	0.1	0.5	0.5	0.8	1.4	0.4	0.5	0.4	0.3	0.2	0.0	0.3	0.6	0.9	1.6	0.5	0.0	0.9	0.1	0.1	0.4	0.3	0.3	0.6	1.5	0.8	0.1	0.5	3.1	0.7	0.3	0.2	0.6	0.1	0.9	2.6	0.2	0.7	0.2	0.9	1.6	0.8	0.6	0.6	0.6	0.5	1.8	0.4	0.3	0.5	0.1	0.3	0.9	0.1	1.7	1.3	1.5	2.5	0.8	1.4	0.7	0.8	1.1	0.2	1.3	0.6	0.6	0.3	0.9	0.5	0.6	1.4	0.7	0.4	0.3	1.6	0.9	0.8	1.2	0.6	0.4	1.5	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0
SEMG2	SGII	ENSG00000124157	"Semenogelin II"	Q02383	20	45221300-45224458	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"ductus deferens: 1137.0;seminal vesicle: 1095.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"prostate cancer: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042767, HPA042835"	Enhanced				"Secreted in male reproductive system"	920000	920000			"HPA042767: AB_10959312, HPA042835: AB_10964060"												"unprognostic (1.39e-1)"		"unprognostic (2.17e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1137.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	46.2	0.0	0.0	0.1	1095.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	8.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PATE2	"C11orf38, LVLF3112, PATE-M, UNQ3112"	ENSG00000196844	"Prostate and testis expressed 2"	Q6UY27	11	125776113-125778819	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"ductus deferens: 56.1;epididymis: 112.4;seminal vesicle: 44.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"						"unprognostic (3.28e-1)"				"unprognostic (7.26e-2)"	"unprognostic (2.95e-1)"		"unprognostic (1.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.84e-3)"		"unprognostic (1.55e-2)"		"unprognostic (5.08e-1)"	"unprognostic (2.55e-1)"			0.1	0.1	0.4	0.0	1.0	0.1	0.1	0.7	0.6	0.1	0.2	0.0	56.1	0.0	0.1	112.4	0.0	0.1	0.0	0.2	0.5	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	44.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	4.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.2	1.6	0.6	0.2	1.0	0.0	0.9	0.0	0.2	0.7	0.4	0.0	1.7	0.5	0.2	0.6	0.3	0.4	0.8	0.2	0.6	0.5	0.4	0.1	0.3	0.8	0.7	0.3	0.7	1.1	0.0	0.0	0.7	1.4	0.0	0.1	0.7	0.5	0.0	0.6	1.7	0.1	1.6	0.5	4.4	1.6	1.6	1.2	0.1	1.9	0.7	0.7	0.4	0.5	2.6	1.6	0.3	1.4	2.0	2.7	0.8	0.6	0.9	0.6	0.9	0.5	0.8	1.5	0.7	1.5	0.7	0.6	0.6	0.3	0.6	0.2	0.3	0.2	0.1	0.2	0.5	1.0	0.3	1.6	0.2	0.3	0.2	0.3	0.0	0.4	1.0	0.7	0.6	0.5	0.9	1.1	0.0	0.0	0.0
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor, Kazal type 13 (putative)"	Q1W4C9	5	148268180-148286254	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7"	"Cell line enriched"	"Detected in some"	20	"HeLa: 99.6"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036456	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"			"Plasma membrane"	"Plasma membrane"	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.2	0.0	85.5	0.0	0.4	86.8	0.1	1.0	0.1	0.8	0.0	0.1	2.1	0.0	0.1	0.1	0.0	0.0	1.4	0.4	0.0	1.0	0.1	0.0	4.0	0.0	0.0	0.1	26.7	0.1	0.2	0.0	0.1	0.0	0.0	2.9	2.7	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	99.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"ductus deferens: 16.9;kidney: 33.4"	"Cell line enhanced"	"Detected in some"		"BJ: 2.8;BJ hTERT+: 1.7;fHDF/TERT166: 6.8;TIME: 1.5;U-2197: 2.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028701	Enhanced									"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	1.7	1.2	0.4	0.0	0.0	0.0	0.6	6.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.1	0.0	1.5	0.1	1.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478793-34513805	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	11	"breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9"	"Group enriched"	"Detected in some"	8	"RT4: 17.4;T-47d: 33.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062706			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favourable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	48.8	0.0	0.0	0.5	0.0	0.0	72.2	0.6	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	6.5	0.0	2.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.0	1.4	0.0	0.0	85.1	86.9	0.0	3.5	0.0	1.0	0.0	0.3	0.1	0.1	0.0	0.2	0.0	3.5	1.0	5.8	1.2	0.5	0.5	2.0	1.8	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.4	0.0	0.0	0.0	3.0	0.0	33.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.0	0.3	0.2	0.5	1.8	0.3	0.2	0.3	0.4	0.3	0.5	0.4	0.4	0.9	0.7	1.8	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 93.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.5	0.5	0.0	21.3	93.1	0.1	0.8	3.3	3.9	0.0	0.0	0.1	2.8	0.0	1.7	0.3	0.0	0.0	0.1	0.5	0.0	3.1	0.0	0.1	0.2	0.6	2.6	6.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.0	0.1	0.3	4.5	0.1	3.1	0.1	0.0	0.0	0.0	6.5	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9
KCP	"CRIM2, FLJ33365, NET67"	ENSG00000135253	"Kielin/chordin-like protein"		7	128862451-128910719	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;HMC-1: 7.6;U-87 MG: 3.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (6.12e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.33e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.01e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.64e-3)"	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	30.0	0.9	0.1	1.7	0.4	0.6	2.1	0.3	0.0		11.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	28.3	0.0	0.0	2.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	13.4	0.2	2.0	0.0	1.0	0.0	0.0	0.0	1.8	0.1	0.9	0.0	1.1	0.2	0.0	7.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PAEP	"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14"	ENSG00000122133	"Progestagen associated endometrial protein"	P09466	9	135561756-135566955	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"ductus deferens: 176.9;endometrium 1: 79.9;placenta: 105.3"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 21.5"	"Cancer enriched"	"Detected in many"	8	"melanoma: 275.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"									"CAB016762, HPA020108, HPA029473"	Enhanced				"Secreted in female reproductive system"					"CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147"	"unprognostic (3.39e-2)"	"unprognostic (8.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.61e-6)"	"unprognostic (1.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.93e-3)"		"prognostic unfavourable (0.00e+0)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (4.24e-1)"		"unprognostic (4.98e-2)"	0.3	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	1.3	0.1	0.0	176.9	0.2	79.9	0.1	0.1	5.0	0.0	0.1	0.1	0.3	0.1	0.3	0.4	0.0	0.1	0.0	0.8	0.1	0.0	0.2	105.3	0.0	1.1	0.0	0.0	0.2	13.9	0.1	1.1	0.1	0.0	0.1	0.2	2.0	0.5	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.3	1.3	5.8	0.9	0.8	0.8	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.6	2.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1	3.0	0.5	0.0	0.3	0.0	0.7	0.5	0.0	0.2	0.2	0.4	0.0	0.1	0.4	0.2	0.1	0.2	21.5	0.4	0.2	0.0	0.1	1.1	0.2	0.1	1.0	2.0	0.2	0.3	0.3	0.4	5.8	0.9	0.6	0.6	0.5	0.5	0.6	0.8	0.6	0.3	1.3	0.7	0.8	4.0	0.8	0.8	1.3	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0
EDDM3A	"FAM12A, HE3-ALPHA"	ENSG00000181562	"Epididymal protein 3A"	Q14507	14	20745892-20748380	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ductus deferens: 61.8;epididymis: 129.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.3;SH-SY5Y: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"									HPA049952	Approved				"Secreted in male reproductive system"					"HPA049952: AB_2680970"	"unprognostic (1.42e-1)"				"unprognostic (9.88e-2)"								"unprognostic (8.56e-3)"		"unprognostic (2.10e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	61.8	0.0	0.1	129.9	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.2	14.7	0.1	0.1	0.1	0.0	0.1	0.4	0.4	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 155.4;hTCEpi: 182.5;SiHa: 54.7;THP-1: 46.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	2600000	2600000	"Golgi apparatus"	"Golgi apparatus"	"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	155.4	0.0	11.6	0.0	5.6	0.0	0.7	0.0	0.0	20.8	0.0	30.0	0.0	0.0	0.8	182.5	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.6	0.0	0.0	0.0	31.6	1.2	0.0	0.0	54.7	11.7	0.1	0.2	46.2	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 sigma 3 subunit"	Q96PC3	2	223751686-223838027	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA066782	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavourable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	1.9	1.4	1.6	5.4	3.0	1.8	1.6	2.2	1.9	1.6	1.8	0.2	50.0	3.1	0.8	64.5	5.8	1.7	7.6	1.0	2.3	1.7	7.0	1.9	5.2	3.8	1.1	1.0	0.8	5.1	3.3	6.8	4.6	0.9	2.5	2.0	1.9	4.1	39.6	0.5	1.6	4.1	0.9	1.0	3.1	6.2	1.1	0.4	0.8	10.5	3.1	5.7	8.1	2.9	8.8	5.3	4.9	0.5	0.7	1.6	0.7	8.9	8.5	1.0	3.2	0.5	0.2	4.6	3.7	0.9	1.9	1.7	55.0	7.0	3.5	3.1	0.5	14.8	2.7	10.2	2.8	5.1	4.3	0.3	13.5	5.6	0.2	1.1	0.4	0.1	11.1	3.4	11.7	1.3	0.5	0.8	1.1	3.8	0.1	0.2	1.2	6.0	1.3	0.0	1.5	17.4	17.6	2.5	0.7	2.0	3.6	1.2	1.7	1.6	0.6	0.3	1.9	1.0	2.9	3.5	3.0	9.6	1.3	0.4	2.0	4.9	0.5	0.4	1.1	0.3	0.8	8.8	0.5	0.4	2.2	3.5	0.4	0.7	1.9	0.7	0.2	5.3	1.6	0.7	1.6	3.0	2.2	1.9	2.3	1.7	1.1	1.0	0.9	0.4
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166097	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 15.7;epididymis: 53.6;testis: 15.8"	"Group enriched"	"Detected in some"	6	"HAP1: 5.7;NTERA-2: 4.8;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	1.1	1.2	1.1	0.1	1.9	0.1	2.3	0.5	2.1	1.9	0.9	0.0	15.7	0.1	2.4	53.6	0.5	3.0	0.2	0.4	1.0	3.9	0.4	0.1	0.2	0.2	1.0	1.7	1.9	0.2	2.4	1.3	0.1	1.3	2.0	0.2	0.2	0.6	5.6	0.4	0.5	0.5	2.0	0.8	0.2	0.7	15.8	0.1	0.0	0.4	0.0	0.3	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.5	2.1	1.0	3.9	1.0	1.7	1.3	0.1
DEFB132	"DEFB32, RP5-1103G7.6"	ENSG00000186458	"Defensin beta 132"	Q7Z7B7	20	257736-261096	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 37.1;epididymis: 119.7"	"Group enriched"	"Detected in some"	7	"BEWO: 1.1;NB-4: 3.2;RPMI-8226: 1.8;SH-SY5Y: 1.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046399	Approved				"Secreted in male reproductive system"					"HPA046399: AB_10960992"	"unprognostic (9.27e-3)"						"unprognostic (1.61e-2)"					"unprognostic (2.54e-2)"						17.2	0.1	0.1	0.0	0.1	0.0	4.4	0.1	0.1	0.1	0.1	0.0	37.1	0.0	0.1	119.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.1	6.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.3	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.6;HDLM-2: 9.2;HEK 293: 21.2;LHCN-M2: 10.8;RPTEC TERT1: 22.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.2	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.6	3.2	0.0	0.0	0.0	0.0	9.2	21.2	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	1.3	6.1	0.0	10.8	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	22.5	0.5	0.0	0.0	0.3	0.0	3.0	0.2	0.0	5.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621159-48626356	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 77.4;HEK 293: 29.8;HMC-1: 30.6;K-562: 32.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031463			Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA031463: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	0.8	0.1	1.9	0.2	0.0	0.4	0.1	0.3	5.3	16.6	0.1	27.3	0.0	1.4	42.8	0.1	0.4	0.1	0.1	0.1	0.1	15.3	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.5	0.2	1.1	10.4	0.1	0.1	23.5	0.2	0.2	11.3	1.0	3.5	0.2	0.2	2.0	0.1	0.1	0.1	0.1	0.1	2.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	1.3	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	1.6	0.0	8.3	0.2	0.0	1.3	0.0	0.0	77.4	29.8	13.5	0.5	0.0	0.5	0.2	30.6	0.0	0.0	0.0	0.8	0.0	32.8	0.0	1.3	0.0	0.0	0.1	0.0	1.2	0.0	5.2	0.4	13.5	0.0	0.0	0.0	1.0	0.0	8.5	0.1	0.0	0.1	0.0	7.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 19.2"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Group enriched"	"Detected in some"	6	"amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA060584	Enhanced				"Secreted in other tissues"					"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.4	0.1	0.4	0.0	0.1	0.1	4.9	0.1	12.8	0.1	12.0	16.5	0.1	2.0	0.1	0.0	0.1	1.9	1.7	0.1	0.1	0.1	2.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0.0	5.2	0.1	0.7	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7"	"Cell line enriched"	"Detected in some"	15	"BEWO: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"					"HPA060941: AB_2732654"					"unprognostic (7.64e-4)"													0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.2	2.1	0.2	0.0	0.1	17.2	0.0	0.0	5.0	0.0	0.5	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.3	0.9	0.0	0.1	0.0
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 6.9;SK-MEL-30: 2.2;U-937: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.6	0.0	0.1	0.0	0.2	0.1	2.4	0.0	0.2	1.4	0.0	0.0	21.5	0.0	0.6	0.6	0.2	0.1	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.3	0.0	0.1	0.2	0.0	1.9	1.5	17.7	0.0	4.1	0.0	0.0	0.3	0.0	0.4	1.6	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.4	0.4	3.1	0.3	0.1	0.3	0.0	0.0	0.0	1.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.3	1.0	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.1	0.3	2.2	0.1	0.6	0.0	0.2	0.9	0.0	0.1	0.1	0.6	0.2	0.2	3.5	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 73.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	7	"monocytes: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"			Nucleoplasm	Nucleoplasm	"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	3.0	249.6	41.7	0.1	0.0	3.3	0.3	16.8	0.1	0.1	0.1	0.1	0.3	139.4	0.0	0.1	0.0	0.1	798.6	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.1	35.9	0.1	0.1	0.1	0.0	0.1	0.1	963.7	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.7	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"			"Nuclear speckles, Cytoplasmic bodies"	"Nuclear speckles, Cytoplasmic bodies"	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favourable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.7	0.2	0.5	0.1	0.0	0.2	0.0	0.0	23.4	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 94.6;ductus deferens: 53.7;seminal vesicle: 40.7"	"Cell line enhanced"	"Detected in some"		"HEL: 4.7;K-562: 10.2;NB-4: 20.2;NTERA-2: 3.9;SCLC-21H: 5.5;SH-SY5Y: 5.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 27.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.5"	"Group enriched"	"Detected in many"	5	"B-cells: 1.0;T-cells: 2.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in single"			"CAB017029, HPA043412, HPA051005"	Enhanced									"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	2.3	94.6	3.9	0.8	13.8	1.6	5.4	0.9	3.0	1.3	1.9	1.5	53.7	0.9	1.0	2.7	0.9	1.9	0.8	4.9	1.7	5.4	1.0	0.7	1.6	0.8	9.1	1.5	0.9	0.7	2.4	12.9	2.4	3.6	4.3	0.7	0.9	0.7	40.7	10.5	0.8	1.0	0.8	0.7	0.9	0.9	1.3	2.7	0.0	0.7	0.8	0.7	1.3	1.7	1.0	0.0	0.3	0.3	0.0	2.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.4	4.7	0.1	0.4	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.2	3.9	0.0	0.1	0.0	0.3	0.0	0.0	5.5	5.0	0.0	2.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.4	1.0	0.4	1.5	0.0	0.4	0.0	0.7	0.3	0.0	0.3	0.0	0.0	0.3	3.9	13.8	0.9	3.0	1.7	5.4	9.1	1.5	3.6	2.7
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.0;BEWO: 32.9;HaCaT: 43.0;SK-BR-3: 31.6;U-2197: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	19.3	0.0	9.2	31.0	10.7	32.9	1.4	12.7	0.2	0.3	0.9	14.1	0.0	0.5	3.5	43.0	0.1	1.4	0.1	0.0	0.1	0.0	13.7	0.0	0.7	0.0	0.0	6.3	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	1.7	0.0	0.0	0.0	1.0	20.6	0.1	0.7	17.2	31.6	0.1	16.5	0.0	0.1	0.0	0.0	81.7	0.0	0.0	0.0	0.0	16.2	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6
TMEM114		ENSG00000232258	"Transmembrane protein 114"	B3SHH9	16	8537605-8590193	"Disease related genes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 60.1;seminal vesicle: 24.7"	"Group enriched"	"Detected in some"	5	"NTERA-2: 1.5;U-2 OS: 2.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"hypothalamus: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 9.6"															"unprognostic (3.72e-5)"	"unprognostic (2.26e-1)"	"unprognostic (3.98e-3)"		"unprognostic (7.33e-2)"			"unprognostic (2.19e-1)"			"unprognostic (2.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"		0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	60.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.4	0.0	0.0	0.0	24.7	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	8.3	0.1	0.0	0.3	0.0
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Group enriched"	"Detected in some"	5	"A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.8	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.6	0.0	63.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	4.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.8	0.2	4.1	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9
DEFB131A	"DEFB-31, DEFB131"	ENSG00000186146	"Defensin beta 131A"	P59861	4	9444534-9450514	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"ductus deferens: 31.3;epididymis: 65.5"	"Cell line enriched"	"Detected in some"	6	"TIME: 6.7"	"Cancer enriched"	"Detected in single"	18	"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																					"unprognostic (2.11e-1)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	9.0	0.0	31.3	5.5	0.1	65.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	10.9	0.1	0.1	10.3	0.0	0.1	0.1	0.2	0.3	0.0	0.0	8.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296277-62299064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8"	"Group enriched"	"Detected in some"	20	"HL-60: 3.1;Karpas-707: 1.0;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	27.5	0.1	0.1	9.9	0.0	9.5	27.9	0.1	36.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Group enriched"	"Detected in some"	5	"Daudi: 62.1;U-698: 27.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	7.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	8.9	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469706-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7"	"Group enriched"	"Detected in some"	9	"A-431: 26.2;CAPAN-2: 49.1;EFO-21: 41.0;HaCaT: 35.8;RPTEC TERT1: 38.1"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 1815.6"	"Region enriched"	"Detected in single"	5	"basal ganglia: 3.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"					"Group enriched"	"Detected in many"	13	"basal ganglia: 10.7;hypothalamus: 32.7;midbrain: 14.3;pons and medulla: 12.8;thalamus: 8.5"	HPA042302	Enhanced				"Secreted in other tissues"	1300000	1300000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	1.2	0.1	0.3	1.5	3.0	0.0	10.6	0.2	0.6	352.3	11.0	0.4	143.4	0.7	19.4	385.4	4.5	44.6	10.4	0.4	0.3	0.3	135.1	9.9	31.6	0.2	0.3	0.3	20.4	5.0	5.0	14.9	1.3	0.5	27.2	14.7	2.2	343.7	60.9	0.2	2.8	5.0	10.9	0.2	0.1	3.8	15.6	0.5	0.7	45.5	15.3	29.1	21.9	6.9	0.0	1.2	0.0	0.0	0.0	0.0	0.1	26.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	49.1	0.0	41.0	0.0	35.8	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.6	4.3	0.0	0.0	0.0	0.0	38.1	0.3	1.2	0.2	2.4	0.0	0.2	0.7	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	3.0	0.2	0.6	0.3	0.3	0.3	0.3	0.5	0.5
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell line enhanced"	"Detected in many"		"A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"											"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.7	19.9	5.9	0.0	0.2	0.0	34.7	0.7	0.6	1.0	1.7	4.4	0.2	0.0	0.2	0.1	5.8	0.2	0.6	1.5	5.6	0.9	0.2	0.1	5.9	0.0	0.3	0.0	0.1	2.4	2.3	0.1	1.8	0.4	0.0	0.6	11.5	2.7	0.1	2.0	0.0	1.3	0.0	17.4	0.0	4.2	0.1	0.2	4.1	0.4	0.5	0.1	0.0	0.0	0.8	0.7	0.2	0.0	5.5	2.1	0.0	1.5	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 14.6;U-937: 8.5"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA040470	Enhanced									"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.6	4.8	16.5	1.5	15.7	21.3	0.7	22.8	34.0	0.5	0.7	5.3	30.1	5.4	0.5	1.0	0.9	0.7	0.9	2.0	12.4	9.7	2.3	2.6	0.8	2.5	9.6	12.1	0.5	1.9	13.0	2.7	1.1	12.1	0.8	0.8	3.3	0.8	35.8	3.6	0.6	3.3	0.5	4.2	1.2	1.2	23.0	4.7	0.0	0.9	0.0	1.5	0.7	0.3	0.1	0.0	0.6	0.1	1.2	4.2	1.1	0.0	0.0	0.2	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	1.6	0.2	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	1.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	14.6	0.7	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	8.5	0.5	0.6	0.1	0.1	1.5	0.0	3.5	0.1	2.1	4.2	0.0	0.1	3.9	1.8	0.2	1.2	0.0	0.0	0.1	1.1	16.5	15.7	22.8	18.8	12.4	9.7	9.6	12.1	12.1	4.7
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.6	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.4	0.3	1.5	0.8	0.0	0.7	0.3	0.7	0.0	4.7	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.7	3.5	10.3	35.2	8.5	0.0	1.2	0.0	0.0	0.2	0.1	2.4	0.0	0.1	13.3	0.7	0.1	0.0	0.1	0.6	0.0	0.3	0.0	0.3	19.0	12.7	0.9	0.3	1.0	0.5	14.9	0.0	2.6	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4"	"Cell line enhanced"	"Detected in some"		"A549: 31.4;RPTEC TERT1: 75.0;RT4: 44.3;T-47d: 160.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	22000	22000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	0.9	0.9	0.9	23.0	0.9	0.0	5.3	0.9	0.9	52.8	58.8	1.3	160.2	36.5	4.8	51.9	4.0	23.7	147.0	0.9	0.9	0.9	3.3	0.9	19.0	0.0	0.8	0.0	4.0	59.2	0.0	11.3	1.6	0.1	18.8	97.7	0.0	70.0	159.4	0.9	1.1	62.2	3.3	0.8	0.9	107.6	0.9	0.0	0.1	1.1	20.0	97.7	13.2	3.7	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.1	4.7	0.0	0.0	0.0	3.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	10.4	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	18.7	0.1	0.0	0.6	75.0	44.3	0.2	0.2	0.0	12.0	0.0	160.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.0	0.1	0.0
AMELX	"AIH1, AMG"	ENSG00000125363	"Amelogenin, X-linked"	Q99217	X	11293413-11300761	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4"	"Cell line enhanced"	"Detected in single"		"K-562: 1.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.9"	"Region enhanced"	"Detected in single"		"amygdala: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"								"unprognostic (1.76e-1)"									"unprognostic (1.00e-1)"		"unprognostic (2.00e-1)"				0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.3	3.5	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.6	0.5	0.5	0.0	0.7	0.0	0.0
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840815	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.0;epididymis: 102.0"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	3.7	2.3	18.4	2.0	17.9	1.3	5.5	3.0	14.0	8.1	3.5	13.9	40.0	3.1	4.7	102.0	3.8	9.7	3.1	3.7	15.4	10.9	8.2	2.5	3.0	1.6	14.4	10.3	5.4	2.7	8.4	7.0	14.9	18.0	5.6	4.3	1.2	6.9	27.6	25.2	2.7	3.6	3.5	15.7	2.1	3.3	2.7	13.5	0.1	3.8	9.3	1.8	3.2	4.3	0.5	0.2	0.0	0.6	1.9	1.5	0.2	3.0	0.0	17.6	0.7	0.3	0.3	6.5	0.6	0.0	0.0	0.0	7.4	0.6	0.4	3.6	2.7	6.4	19.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	3.9	0.5	0.1	0.0	0.0	0.4	0.3	4.8	0.2	7.8	0.1	6.1	5.4	0.1	8.2	8.1	0.0	6.0	0.1	0.0	6.8	0.6	0.1	0.1	2.2	5.2	0.0	7.0	0.5	0.0	0.0	0.8	0.1	4.5	0.0	0.0	0.0	1.1	0.4	1.5	0.5	0.7	1.0	0.2	0.2	0.7	0.6	0.0	1.9	0.6	0.2	1.0	0.2	18.4	17.9	3.0	14.0	15.4	10.9	14.4	10.3	18.0	13.5
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Group enriched"	"Detected in some"	13	"A549: 23.3;HDLM-2: 12.0"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982017-150995634	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 62.0;seminal vesicle: 78.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 12.0;CAPAN-2: 14.4;Hep G2: 14.5;MCF7: 19.3;T-47d: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	2.4	1.1	1.2	0.9	1.2	0.3	2.6	1.3	2.5	2.3	0.9	0.6	62.0	1.4	6.0	11.6	10.7	2.3	12.5	1.9	1.4	1.0	12.1	15.8	1.2	0.5	1.8	0.8	1.8	32.0	9.9	1.2	0.7	1.3	4.1	0.0	1.2	2.5	78.1	0.9	18.9	1.2	0.9	3.2	1.0	1.3	3.6	0.6	1.3	10.4	9.1	21.1	4.5	4.4	0.5	3.8	2.5	3.1	0.1	0.8	0.8	3.9	0.9	1.4	1.4	0.0	0.0	4.1	0.3	0.2	0.0	0.0	12.0	14.4	0.1	0.8	0.0	2.4	0.0	0.2	0.0	1.2	1.4	2.0	1.4	14.5	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.9	4.4	0.0	19.3	0.1	1.0	0.3	0.2	0.9	0.2	4.7	0.0	5.6	2.1	1.2	0.8	9.9	0.5	48.0	1.2	1.5	0.3	0.4	0.2	0.2	1.3	4.0	6.2	2.1	1.3	1.1	0.0	3.1	1.8	0.1	1.8	0.8	0.5	0.3	0.5	3.8	0.1	0.8	0.2	2.5	0.1	0.4	0.0	0.0	0.8	1.2	1.2	1.3	0.9	1.4	1.0	1.8	0.8	1.3	0.6
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.7;ductus deferens: 14.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;HDLM-2: 4.2;Karpas-707: 11.0;U-266/70: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdTCR: 15.7;MAIT T-cell: 6.6;memory CD4 T-cell: 8.6;memory CD8 T-cell: 13.2;naive CD8 T-cell: 6.4;NK-cell: 11.8;T-reg: 7.5"	"Group enriched"	"Detected in many"	14	"NK-cells: 11.8;T-cells: 15.7"									"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favourable (8.43e-7)"	1.7	2.2	0.7	6.2	1.2	4.9	1.0	0.8	0.9	1.5	2.3	0.9	14.1	0.4	1.7	6.4	1.5	1.9	2.7	5.9	0.7	0.7	2.3	1.3	4.2	5.3	2.0	1.0	0.9	3.8	0.8	2.0	1.3	1.2	1.6	5.6	1.1	3.3	3.6	2.7	0.5	2.7	1.6	2.1	7.5	2.0	4.0	0.3	3.7	1.8	1.2	5.5	3.1	1.5	1.0	0.1	0.0	1.0	11.8	15.7	2.9	0.0	0.7	0.1	0.0	0.0	0.4	3.2	0.0	0.2	0.3	0.1	0.0	0.3	4.3	1.6	0.4	0.2	0.0	0.9	0.0	4.2	0.5	1.0	0.2	0.1	0.4	0.0	3.2	2.8	2.5	0.3	0.4	0.0	0.0	11.0	1.3	1.3	2.0	0.4	0.0	0.0	2.3	0.0	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	7.4	1.0	0.2	0.3	1.8	0.1	0.0	0.2	0.0	15.7	0.3	6.6	1.0	8.6	13.2	0.1	0.3	0.5	6.4	0.0	11.8	1.0	0.0	7.5	2.9	0.7	1.2	0.8	0.9	0.7	0.7	2.0	1.0	1.2	0.3
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11137543-11665701	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 57.3;seminal vesicle: 58.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.8;ASC TERT1: 19.2;HEL: 18.9;HMC-1: 13.3;HSkMC: 18.9;K-562: 13.7;RT4: 10.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	920000	920000	Cytosol	Cytosol	"HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253"	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	9.4	1.2	16.7	2.6	10.0	0.7	6.3	0.6	2.9	9.5	11.7	4.1	57.3	2.0	10.2	9.0	4.1	7.6	5.4	3.6	5.6	4.3	6.0	1.1	8.7	1.2	2.3	3.6	15.1	1.9	1.1	6.6	6.2	2.7	24.8	3.7	3.2	2.5	58.8	8.0	2.3	4.2	12.1	3.1	5.0	4.1	2.2	3.3	0.0	25.9	3.1	1.4	14.3	8.0	1.3	0.2	1.0	0.9	0.0	0.1	2.7	0.0	0.0	1.3	0.0	14.8	19.2	0.3	0.1	0.3	0.7	0.5	0.1	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.7	0.0	0.2	18.9	0.0	0.0	5.4	0.0	13.3	18.9	0.0	1.3	0.0	0.3	13.7	6.4	0.8	0.0	0.0	0.0	0.3	0.2	0.0	6.3	8.0	4.5	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	3.8	0.1	0.3	0.0	0.0	0.1	0.0	2.0	1.0	0.3	0.5	0.0	0.9	0.0	1.3	0.0	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.7	0.2	0.0	2.7	16.7	10.0	0.6	2.9	5.6	4.3	2.3	3.6	2.7	3.3
ARHGAP8	"BPGAP1, FLJ20185"	ENSG00000241484	"Rho GTPase activating protein 8"	P85298	22	44752558-44862788	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.3"	"Cell line enhanced"	"Detected in some"		"A-431: 12.2;BEWO: 23.0;CACO-2: 14.6;HEK 293: 19.9;MCF7: 20.6;SK-BR-3: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in single"											HPA069694	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA069694: AB_2686173"	"unprognostic (4.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.78e-3)"	"unprognostic (9.58e-2)"	"unprognostic (7.65e-6)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.22e-2)"	0.5	0.1	1.7	5.6	0.4	0.2	7.5	0.3	0.4	2.2	10.6	0.6	29.3	1.2	2.6	13.0	5.7	6.1	11.5	0.3	0.3	0.4	18.2	0.9	3.9	0.3	0.3	0.3	0.9	14.6	4.5	5.2	22.4	1.2	10.0	5.7	1.9	28.4	24.8	0.3	1.4	3.6	1.2	0.3	6.7	4.3	3.0	0.3	0.7	15.2	2.4	4.9	2.0	1.8	0.2	0.7	0.2	0.4	0.1	2.2	0.3	12.2	0.1	0.2	0.1	0.0	0.2	23.0	0.1	1.5	0.0	0.1	14.6	6.6	0.1	0.7	0.0	9.2	4.3	10.5	0.1	0.0	19.9	0.0	0.3	0.1	0.0	0.0	0.2	0.1	4.6	0.1	0.2	0.0	0.4	0.3	0.0	20.6	0.0	0.0	3.1	0.0	0.0	0.0	0.2	5.6	8.4	1.3	0.0	0.0	19.9	0.4	8.6	0.1	0.1	0.0	0.7	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.6	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	0.7	2.2	0.3	1.7	0.4	0.3	0.4	0.3	0.4	0.3	0.3	1.2	0.3
ARHGEF37	FLJ41603	ENSG00000183111	"Rho guanine nucleotide exchange factor 37"	A1IGU5	5	149551947-149634968	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 66.1;seminal vesicle: 73.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.9;HaCaT: 18.2;hTCEpi: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.0"	"Region enhanced"	"Detected in some"		"cerebellum: 9.5"	"Low region specificity"	"Detected in all"			"HPA043885, HPA053487"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA043885: AB_2678715, HPA053487: AB_2682167"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.16e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.10e-1)"	2.5	2.7	10.8	1.9	13.2	3.0	16.8	6.7	7.1	4.0	10.2	17.5	66.1	4.5	4.4	9.5	7.6	7.4	4.6	6.4	12.8	9.5	4.6	1.4	4.3	1.0	19.1	5.8	2.2	7.0	29.6	5.3	3.6	12.3	16.0	5.2	12.0	23.2	73.8	11.9	29.3	4.8	7.0	31.7	1.0	11.7	4.8	15.1	0.7	2.1	4.8	3.4	6.4	5.4	0.7	1.1	9.0	1.2	0.2	0.8	0.0	2.9	1.1	0.8	3.6	0.2	0.4	2.1	0.4	0.6	0.6	0.6	0.0	3.9	0.4	9.9	0.4	18.2	0.3	1.8	1.2	0.8	0.9	0.3	1.8	0.2	0.7	0.0	0.5	0.5	24.2	1.8	2.4	2.9	0.4	0.7	0.0	0.4	0.5	0.5	0.2	2.2	0.3	0.4	0.0	4.0	1.5	1.5	3.5	2.2	0.2	0.3	5.4	0.1	2.3	0.2	0.7	0.0	0.5	0.5	1.0	0.3	0.7	0.1	2.5	9.0	0.9	0.5	0.4	1.2	0.5	0.2	0.3	0.3	0.3	0.7	0.8	0.6	4.9	0.2	0.5	1.1	0.2	0.0	10.8	13.2	6.7	7.1	12.8	9.5	19.1	5.8	12.3	15.1
ASCL2	"ASH2, bHLHa45, HASH2"	ENSG00000183734	"Achaete-scute family bHLH transcription factor 2"	Q99929	11	2268495-2270952	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.8;placenta: 16.0"	"Group enriched"	"Detected in some"	5	"BEWO: 18.7;NB-4: 5.5;SCLC-21H: 15.3"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 76.1;stomach cancer: 23.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.71e-3)"	"prognostic favourable (5.11e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.22e-2)"	"prognostic favourable (4.73e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.45e-6)"	"unprognostic (8.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.12e-4)"	"unprognostic (1.07e-3)"	0.5	0.3	0.7	2.2	1.3	0.9	1.1	0.0	1.2	2.7	7.3	1.4	21.8	9.2	3.6	1.2	2.5	0.7	0.4	0.8	0.6	0.4	2.5	1.1	0.9	0.9	1.5	0.6	0.4	1.5	0.0	0.1	16.0	1.1	3.3	3.4	0.1	9.7	9.5	0.6	10.0	7.3	0.2	3.7	3.0	2.8	1.6	1.1	1.1	0.7	0.8	2.7	3.6	3.3	0.1	1.0	8.6	2.0	0.0	3.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	1.7	0.0	0.0	1.9	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.4	15.3	0.0	0.0	0.3	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.5	1.4	8.6	3.0	2.0	0.2	0.1	0.7	1.7	1.0	0.0	0.2	1.7	1.2	0.0	1.7	0.0	0.0	0.3	0.7	1.3	0.0	1.2	0.6	0.4	1.5	0.6	1.1	1.1
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721649-10785110	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8"	"Group enriched"	"Detected in some"	8	"BEWO: 39.7;SK-BR-3: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	1.4	0.9	0.4	0.4	0.5	1.1	2.4	0.5	0.8	21.2	0.8	0.6	49.3	0.1	2.1	30.5	6.9	0.8	0.8	0.7	0.8	0.3	13.2	2.0	0.8	0.5	0.4	0.4	0.9	1.1	0.1	8.9	39.0	0.5	1.8	0.7	54.4	41.8	15.1	0.4	36.7	0.7	0.4	0.6	1.3	0.6	0.8	0.4	0.9	1.4	6.0	3.5	0.5	7.2	1.1	0.8	0.6	1.7	0.9	2.2	1.1	0.3	0.4	1.2	1.4	0.0	0.0	39.7	0.5	0.0	0.0	0.0	0.7	1.0	1.0	0.8	0.0	0.6	0.6	0.0	0.0	0.5	1.5	0.5	0.6	1.4	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	0.4	1.9	0.0	1.2	0.3	1.5	1.0	0.4	0.8	0.7	3.2	0.0	0.9	1.0	1.3	0.3	14.2	0.4	1.4	2.1	0.2	0.5	1.0	0.5	0.5	3.4	1.0	0.6	0.6	0.8	0.4	0.3	0.8	0.6	2.2	1.7	1.3	1.1	1.0	1.7	0.5	0.9	1.0	0.5	0.0	0.9	0.8	0.8	0.9	1.1	0.4	0.5	0.5	0.8	0.8	0.3	0.4	0.4	0.5	0.4
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Cell line enhanced"	"Detected in many"		"A549: 18.3;MCF7: 9.2;SH-SY5Y: 15.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favourable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.3	4.9	0.0	1.9	4.5	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	1.0	2.9	6.7	0.0	0.0	4.5	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.5	2.8	5.6	0.0	0.0	0.0	7.0	9.2	0.6	0.1	1.8	3.1	0.1	2.7	0.1	3.5	0.1	0.2	15.3	0.2	2.5	2.5	1.9	0.0	0.0	3.9	3.1	0.1	3.3	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747445-132754403	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 17.4;seminal vesicle: 15.7"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 23.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favourable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.3	0.7	3.4	5.6	3.5	0.3	0.3	8.4	4.7	1.2	5.8	3.5	17.4	7.8	0.2	0.7	0.5	0.8	5.2	0.6	3.9	2.6	3.8	0.3	0.7	1.7	3.9	0.5	0.3	7.4	0.4	0.9	0.5	4.1	1.7	6.5	1.5	8.4	15.7	0.7	0.7	8.9	0.4	7.2	0.8	5.5	1.4	3.9	7.0	0.8	0.7	2.1	2.4	0.3	0.3	0.1	0.7	0.1	0.2	2.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	23.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.3	0.1	2.7	0.3	2.1	2.1	0.0	0.3	1.8	0.9	0.3	0.2	0.1	0.1	2.7	0.3	3.4	3.5	8.4	2.8	3.9	2.6	3.9	0.5	4.1	3.9
CCNO	"CCNU, FLJ22422, UDG2, UNG2"	ENSG00000152669	"Cyclin O"	P22674	5	55231152-55233680	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.1;epididymis: 18.2;seminal vesicle: 23.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.5;T-47d: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA050090	Uncertain									"HPA050090: AB_2681011"	"unprognostic (3.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-2)"	"prognostic favourable (6.78e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.18e-3)"	"prognostic favourable (7.60e-4)"	"unprognostic (3.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.03e-2)"	"prognostic favourable (5.10e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.88e-3)"	0.7	0.8	1.3	0.8	7.2	0.6	0.7	1.7	4.5	1.9	1.2	1.3	28.1	1.4	1.1	18.2	0.9	4.0	3.5	0.6	1.3	2.0	2.2	0.7	1.3	0.8	0.1	1.6	1.4	9.5	3.0	5.4	0.8	4.3	1.8	0.5	1.6	6.5	23.2	0.5	3.1	2.1	0.6	0.1	0.6	5.3	12.2	0.1	0.0	7.4	0.8	0.9	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.3	3.8	0.0	1.4	0.3	0.0	6.5	0.0	0.0	0.5	0.6	0.0	3.9	0.0	2.7	0.0	3.0	0.1	0.0	0.0	0.0	5.0	0.1	2.8	0.4	0.0	0.4	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.1	0.5	5.4	1.9	0.4	0.1	1.3	0.9	2.9	0.0	4.6	1.2	1.0	8.8	0.5	0.3	0.0	3.1	3.6	1.6	3.4	1.8	0.0	2.3	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	7.2	1.7	4.5	1.3	2.0	0.1	1.6	4.3	0.1
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favourable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	12.7	10.4	23.4	14.2	4.8	10.3	10.2	17.9	8.6	11.5	12.4	25.4	28.3	33.4	18.5	7.0	15.4	14.3	9.4	14.2	20.9	6.6	61.9	8.7	13.0	1.5	31.6	11.8	5.3	2.0	14.5	10.3	13.6	31.3	29.4	15.1	6.6	46.9	15.5	23.7	9.4	28.6	21.9	17.5	10.6	17.0	14.8	15.7	14.7	10.2	4.3	27.5	10.3	9.1	16.6	14.1	8.0	16.4	6.6	11.8	47.6	6.1	23.8	19.4	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5
CPNE7		ENSG00000178773	"Copine 7"	Q9UBL6	16	89575768-89597246	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.5;epididymis: 26.2;seminal vesicle: 21.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 42.6;TIME: 23.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043359	Uncertain									"HPA043359: AB_10794884"	"unprognostic (6.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (9.52e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (7.22e-4)"	0.4	0.9	9.5	1.4	6.4	1.3	1.6	0.0	14.2	1.7	0.8	3.3	34.5	4.8	0.9	26.2	1.6	1.6	4.4	0.7	8.0	14.6	3.3	0.9	1.4	0.9	4.0	9.3	0.7	1.1	0.8	11.0	0.6	4.1	1.9	0.4	0.7	2.0	21.9	0.2	2.3	2.8	0.5	0.7	1.0	4.5	2.7	1.0	1.7	0.6	0.0	0.8	1.4	0.8	0.0	0.0	0.2	0.0	1.2	8.5	0.4	0.0	9.8	0.1	0.1	16.7	17.4	0.1	4.2	1.7	5.9	4.6	9.7	8.2	0.0	3.8	1.6	6.6	6.1	0.2	2.0	2.3	4.8	0.1	7.3	0.1	42.6	0.0	1.6	6.8	0.4	3.1	11.7	0.1	10.3	0.1	14.1	1.4	3.0	1.8	6.4	7.5	0.1	0.0	6.7	0.8	0.0	5.5	0.0	1.4	2.0	0.4	1.8	1.2	23.1	11.5	0.0	7.0	0.0	0.0	0.0	1.8	11.3	6.7	4.7	0.0	0.0	0.2	1.1	0.0	8.5	0.0	2.0	3.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.3	0.4	9.5	6.4	0.0	14.2	8.0	14.6	4.0	9.3	4.1	1.0
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727384-49744437	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3"	"Group enriched"	"Detected in some"	65	"HEL: 14.2;RT4: 4.8;SK-BR-3: 10.8;T-47d: 5.3"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"neutrophil: 6.0;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	45	"granulocytes: 6.0;monocytes: 2.9"					"Low region specificity"	"Detected in many"			HPA054392	Supported				"Secreted in other tissues"	390000000	390000000			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.2	0.2	0.0	0.2	33.5	0.2	0.2	0.2	11.1	0.2	0.0	156.3	0.0	0.7	0.0	45.3	117.6	2.0	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.2	0.0	15.9	1.7	0.0	0.2	0.0	0.0	3.0	0.0	0.0	233.3	17.7	0.2	0.6	0.2	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.2	56.7	14.8	1.2	14.4	0.0	0.0	6.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	10.8	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.9	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4"	"Cell line enriched"	"Detected in single"	77	"HDLM-2: 43.7"	"Group enriched"	"Detected in many"	6	"melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 37.2"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 37.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046528	Uncertain									"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.0	11.4	3.4	3.9	4.2	0.7	1.0	1.6	8.0	0.9	1.0	1.1	25.1	2.1	1.3	1.7	0.7	3.4	1.6	11.5	4.1	3.4	1.8	1.0	1.5	4.4	3.3	1.5	5.4	0.5	0.7	2.3	22.6	3.7	3.4	1.1	2.9	0.7	22.4	0.5	1.3	2.5	0.7	2.3	6.9	1.1	1.0	2.9	1.0	1.1	0.5	1.5	1.0	1.2	0.0	0.9	37.2	3.2	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.0	37.2	0.2	3.2	0.0	0.0	0.4	0.0	0.9	0.0	0.5	0.1	0.1	0.4	2.0	0.0	0.3	0.4	3.4	4.2	1.6	8.0	4.1	3.4	3.3	1.5	3.7	2.9
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114344	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 151.5;gallbladder: 80.4"	"Cell line enriched"	"Detected in some"	8	"HaCaT: 11.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in some"														"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.1	0.6	0.1	8.4	0.3	0.0	0.1	0.1	0.2	5.1	3.2	0.2	151.5	0.3	0.4	0.8	10.9	0.0	80.4	0.3	0.1	0.0	0.3	0.8	1.2	0.1	0.1	0.1	0.2	0.8	0.0	0.1	0.2	0.2	3.4	1.4	0.4	7.3	1.2	0.6	2.1	3.5	0.6	0.1	0.1	14.9	0.5	0.1	0.1	29.0	6.1	6.6	20.4	9.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	11.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.3	0.2	0.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
DUOXA2		ENSG00000140274	"Dual oxidase maturation factor 2"	Q1HG44	15	45114321-45118421	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 78.3;gallbladder: 38.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.3;EFO-21: 1.9;HDLM-2: 1.0;U-2 OS: 3.9;U-266/84: 1.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA063548	Enhanced									"HPA063548: AB_2685037"	"unprognostic (1.87e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-4)"	"unprognostic (9.75e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.54e-2)"	0.0	0.3	0.0	3.2	0.0	0.0	0.4	0.0	0.0	3.6	1.9	0.0	78.3	0.2	0.1	0.2	5.6	0.0	38.9	0.5	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.4	0.0	0.0	0.0	1.5	0.2	0.0	0.0	16.5	0.1	0.0	0.0	20.2	3.9	2.9	12.9	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.6	0.6	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 30.0;SK-MEL-30: 46.2;WM-115: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	30.0	17.8	0.8	2.3	0.0	1.5	2.3	12.8	7.0	3.1	0.3	5.7	0.0	6.3	1.0	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.2	13.1	5.7	0.1	1.3	14.0	12.6	0.0	2.1	3.1	18.4	0.3	0.6	2.3	16.1	5.9	0.1	9.9	3.2	15.2	46.2	3.2	0.3	16.0	5.2	0.0	0.0	1.6	3.6	0.4	0.0	15.6	2.6	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.7;HaCaT: 23.9;HBEC3-KT: 26.3;RT4: 53.1;T-47d: 53.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.7	0.0	4.4	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.2	4.7	53.1	0.0	0.0	0.1	3.6	0.0	53.8	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542444-117549546	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 16.8;fHDF/TERT166: 18.6;RPTEC TERT1: 18.7;RT4: 5.9"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favourable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	4.6	0.5	11.5	0.6	10.3	0.5	1.4	0.5	12.5	23.5	0.7	7.3	46.8	0.5	40.5	53.9	0.7	25.4	1.2	0.6	14.7	2.1	25.5	0.5	0.5	0.7	1.8	10.4	5.7	0.5	0.6	1.1	0.6	2.5	1.9	0.5	3.4	1.3	76.3	5.1	4.7	0.5	22.6	0.6	0.5	0.5	3.6	6.2	0.0	0.5	1.2	0.7	4.2	2.4	0.7	0.5	2.4	0.9	1.0	0.7	0.1	0.0	0.0	0.0	1.8	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	16.8	18.6	0.1	0.4	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.1	18.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.6	0.5	0.6	0.7	0.4	0.4	0.4	0.4	0.7	0.6	0.5	1.1	1.0	0.9	0.5	0.6	0.1	11.5	10.3	0.5	12.5	14.7	2.1	1.8	10.4	2.5	6.2
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Group enriched"	"Detected in some"	18	"HEL: 5.0;Hep G2: 16.6;HMC-1: 7.4"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	480000	480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.0	0.0	16.6	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2
FADS2	"D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13"	ENSG00000134824	"Fatty acid desaturase 2"	O95864	11	61792980-61867354	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 204.5;seminal vesicle: 98.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 148.0;HBEC3-KT: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006741	Approved									"HPA006741: AB_1078796"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.21e-2)"	"unprognostic (8.95e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.00e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (3.42e-4)"	7.1	85.9	34.3	10.0	31.7	7.5	20.2	10.1	48.5	23.7	4.9	28.6	204.5	9.3	19.9	10.3	3.2	8.9	6.6	8.2	24.4	29.9	3.8	38.0	9.7	6.7	28.1	20.1	8.6	3.1	41.5	11.8	12.8	26.4	32.0	4.3	16.7	5.0	98.8	3.0	26.1	3.6	39.3	17.9	3.3	3.6	10.4	24.0	8.4	2.5	3.2	9.2	10.6	6.5	3.5	13.3	6.9	9.0	6.3	9.4	3.8	1.3	52.1	77.4	42.7	70.5	148.0	20.2	8.7	78.7	12.8	35.1	3.3	17.5	0.3	1.2	19.2	1.5	50.6	88.5	5.5	0.6	1.0	29.6	10.4	7.6	55.6	1.8	1.7	55.6	2.7	46.6	4.2	37.8	1.6	24.0	5.9	1.3	16.6	9.8	33.7	13.7	22.5	1.3	72.8	50.9	0.4	23.0	28.0	5.7	0.1	2.2	2.1	21.8	15.3	1.4	13.9	0.9	1.2	11.2	9.8	3.9	1.4	9.8	15.7	4.5	5.7	6.9	9.4	9.0	2.2	1.6	3.5	5.0	10.5	3.5	2.0	4.4	3.1	6.3	7.5	13.3	3.0	3.8	34.3	31.7	10.1	25.2	24.4	29.9	28.1	20.1	26.4	24.0
FAM110C		ENSG00000184731	"Family with sequence similarity 110 member C"	Q1W6H9	2	38814-46870	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 41.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.0;HBEC3-KT: 7.9;hTCEpi: 8.0;RPTEC TERT1: 13.7;RT4: 18.8;SK-BR-3: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"			"HPA036144, HPA036145"	Uncertain									"HPA036144: AB_10670710, HPA036145: AB_2674968"	"unprognostic (4.29e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.47e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (7.64e-4)"	"unprognostic (3.07e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.68e-1)"	7.6	2.5	1.7	5.2	1.6	0.0	3.7	0.7	2.1	6.1	9.8	2.4	41.1	7.3	3.2	24.7	31.7	6.1	8.5	2.8	1.5	0.9	13.1	11.6	2.5	0.9	0.8	1.3	5.3	16.4	4.5	3.0	0.8	2.3	6.4	7.1	2.7	4.5	18.9	1.0	6.7	10.7	1.0	2.2	1.1	5.0	4.9	1.3	1.2	4.5	9.0	9.5	7.4	10.0	0.3	0.2	1.0	0.2	0.4	2.4	0.0	3.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.3	0.0	4.8	0.0	10.0	0.0	7.9	0.0	0.6	0.3	0.0	1.2	0.8	0.0	0.0	0.0	0.0	8.0	0.0	1.4	0.0	0.0	0.0	0.0	6.7	4.3	0.0	0.9	2.5	0.0	0.0	0.0	13.7	18.8	0.5	0.0	0.0	8.5	0.0	2.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.2	0.0	0.3	0.2	0.2	1.0	0.4	0.1	0.2	2.4	0.0	1.7	1.6	0.7	2.1	1.5	0.9	0.8	1.3	2.3	1.3
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994949-40043529	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.4;seminal vesicle: 33.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 22.8;hTERT-HME1: 7.2;RT4: 10.9;SCLC-21H: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favourable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.1	0.2	0.1	2.8	0.2	0.8	4.7	0.2	0.3	2.6	6.9	0.1	29.4	3.0	0.2	7.5	15.4	1.1	4.0	1.5	0.2	0.1	4.8	2.1	1.0	0.1	0.2	0.1	0.5	14.4	2.6	2.6	0.5	0.1	6.3	3.1	0.4	7.8	33.3	0.1	13.8	12.5	0.8	0.2	0.1	5.9	24.9	0.1	1.3	12.6	12.8	8.1	3.0	4.1	0.7	0.5	2.7	0.4	0.6	0.3	0.1	4.7	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	7.0	1.4	0.0	0.0	0.0	7.6	0.0	9.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	22.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	10.9	24.1	0.0	0.2	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.3	2.2	0.6	0.3	0.5	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.1
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436172	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 235.4;placenta: 433.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 837.5;HSkMC: 391.7;hTERT-HME1: 230.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	47000000000	47000000000			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (3.44e-8)"	"prognostic unfavourable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (3.33e-4)"	20.2	4.5	3.1	13.0	5.2	0.2	13.1	2.2	4.3	21.9	57.1	4.4	235.4	3.5	25.1	27.5	37.4	26.5	20.9	57.3	3.9	2.9	5.8	166.3	81.5	7.9	4.6	5.0	16.9	3.3	1.7	3.5	433.0	6.1	17.1	25.1	5.1	10.4	141.2	9.8	7.0	13.5	114.9	4.6	1.9	21.8	9.0	2.7	9.4	5.4	17.4	2.6	64.7	16.9	0.2	0.8	0.0	0.6	0.0	0.3	0.0	0.2	1.9	2.6	0.5	106.3	837.5	0.1	43.2	28.8	43.7	31.2	26.1	1.0	0.0	0.2	143.6	4.4	0.4	98.4	23.6	0.0	0.1	0.0	0.6	81.5	76.9	0.0	0.1	391.7	0.6	103.4	230.4	50.7	0.1	0.1	87.2	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.1	1.1	0.3	0.1	0.6	5.1	2.7	28.0	0.4	0.0	97.2	63.4	6.7	69.3	8.0	0.1	0.0	0.0	75.3	0.0	16.4	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	3.1	5.2	2.2	4.3	3.9	2.9	4.6	5.0	6.1	2.7
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.5"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	15.1	10.7	15.2	5.3	13.4	5.4	7.6	10.5	19.8	4.5	5.6	6.8	40.5	17.9	5.1	8.4	8.6	4.6	4.3	7.0	12.9	8.1	6.0	6.6	7.5	2.2	11.3	10.2	2.9	10.0	4.6	6.8	4.3	9.5	7.1	2.2	3.2	12.7	22.9	4.9	22.4	13.0	4.5	10.0	11.5	8.3	16.6	8.8	0.0	4.5	9.2	3.5	3.9	4.7	0.0	1.1	3.1	2.0	0.0	0.2	1.2	8.2	9.6	1.5	6.1	2.4	2.3	9.6	12.3	3.8	5.2	2.7	4.3	5.9	0.0	5.6	6.5	25.1	2.5	7.0	0.9	11.2	1.2	10.8	7.6	3.0	3.0	0.1	7.6	2.4	4.8	5.0	2.0	6.9	5.1	1.7	3.7	7.0	0.2	6.0	2.2	21.7	0.2	4.3	0.7	3.1	5.3	0.5	8.1	9.5	12.8	6.8	12.7	1.7	14.7	33.1	22.8	14.7	12.3	0.1	0.1	0.1	14.6	0.4	8.1	0.0	2.0	3.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.5	0.0	1.4	0.0	0.0	1.2	15.2	13.4	10.5	19.8	12.9	8.1	11.3	10.2	9.5	8.8
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 55.8;HEL: 68.8;HMC-1: 37.2;SH-SY5Y: 65.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 36.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	339	"basophil: 81.2"	"Lineage enriched"	"Detected in single"	813	"granulocytes: 81.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (5.22e-5)"	7.0	6.2	2.1	1.5	2.4	2.5	7.9	1.2	1.9	22.4	2.8	1.4	85.8	2.5	20.6	5.4	3.2	23.0	9.7	4.8	1.5	1.0	7.6	0.6	16.1	2.2	1.8	1.1	4.6	5.8	3.4	4.5	51.8	2.4	27.8	1.8	6.1	1.9	209.1	3.5	4.1	3.4	8.4	1.4	5.1	2.9	2.7	1.5	0.4	3.3	2.7	1.5	22.4	12.4	0.0	0.0	81.2	0.0	0.0	0.0	0.4	4.6	1.1	0.2	3.1	0.4	0.1	55.8	10.4	8.9	3.6	1.3	1.9	2.0	0.1	2.9	6.1	4.9	2.9	0.0	1.5	0.0	1.6	68.8	7.6	3.0	0.8	6.9	37.2	0.0	0.0	0.1	0.0	5.6	18.0	0.1	0.0	1.7	0.0	14.1	0.2	0.3	0.0	1.3	0.0	0.1	4.1	4.3	65.0	2.6	13.8	0.4	2.6	2.8	10.0	0.2	0.1	2.5	1.4	0.0	0.0	0.0	0.1	0.4	0.7	81.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	2.4	1.2	1.9	1.5	1.0	1.8	1.1	2.4	1.5
GREB1L	"C18orf6, FLJ13687, KIAA1772"	ENSG00000141449	"Growth regulation by estrogen in breast cancer 1 like"	Q9C091	18	21242242-21525417	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.0"	"Cell line enhanced"	"Detected in many"		"AF22: 21.6;BEWO: 43.9;CACO-2: 19.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041647, HPA044218"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA041647: AB_2677597, HPA044218: AB_2678859"	"unprognostic (1.88e-3)"	"unprognostic (9.01e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.30e-8)"	"unprognostic (4.72e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-1)"	5.0	3.2	12.5	0.8	5.9	0.8	5.5	2.3	4.5	2.5	1.1	4.0	25.0	0.8	4.9	12.4	0.9	6.7	0.8	9.2	5.5	3.9	1.3	3.9	0.7	0.7	5.6	2.6	7.2	0.5	0.9	3.1	5.4	5.8	3.8	0.7	1.0	1.3	14.2	15.9	2.5	1.5	2.1	2.8	0.6	1.7	12.0	3.0	0.0	7.4	0.0	0.5	0.5	1.7	0.2	0.2	2.8	0.1	0.0	0.6	0.0	0.0	0.3	21.6	0.0	5.0	0.0	43.9	1.1	1.0	1.8	1.6	19.7	1.5	0.0	2.2	3.2	4.1	8.4	1.0	3.2	0.3	4.1	0.0	5.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	4.0	0.0	0.0	0.1	4.3	1.4	0.1	0.1	2.0	2.7	0.0	0.0	0.8	2.0	3.6	1.4	0.0	0.0	0.6	0.1	1.1	0.0	9.0	0.2	1.2	2.1	0.0	0.0	0.2	0.0	0.9	0.0	0.1	2.8	0.1	0.1	0.6	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	12.5	5.9	2.3	4.5	5.5	3.9	5.6	2.6	5.8	3.0
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197843-57226521	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"ductus deferens: 14.7;lymphoid tissue: 15.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 39.5;U-266/84: 12.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.0;plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.5	2.6	2.1	1.4	2.0	4.2	3.5	1.4	2.3	1.4	1.4	1.4	14.7	1.0	1.4	5.7	1.4	1.2	2.1	1.4	2.2	2.3	2.7	4.8	1.5	15.2	3.3	2.4	2.1	2.5	3.4	2.6	3.4	1.4	1.9	0.8	2.3	1.5	7.0	1.4	5.7	1.4	1.4	5.1	4.6	2.1	8.7	2.0	3.0	3.3	1.4	1.8	1.4	1.4	1.5	4.6	0.3	4.0	1.1	0.3	0.5	0.7	0.5	1.4	2.6	0.2	1.0	0.4	0.0	0.2	0.4	0.8	0.2	2.4	1.9	0.4	0.0	0.1	0.7	0.7	0.5	1.0	1.4	2.7	0.7	0.1	1.7	1.0	0.2	2.5	0.7	0.2	1.5	0.3	0.4	2.4	0.1	0.1	1.1	4.9	39.5	0.5	0.4	0.9	1.0	1.9	0.2	0.6	1.9	0.6	0.8	1.5	0.6	4.0	0.3	1.8	0.7	0.6	0.8	7.3	12.2	5.9	0.7	1.7	1.0	0.0	2.1	0.3	0.3	4.0	0.0	1.5	0.1	0.0	1.1	1.1	0.2	0.0	0.3	1.1	0.3	4.6	0.0	0.5	2.1	2.0	1.4	2.3	2.2	2.3	3.3	2.4	1.4	2.0
HOXB2	"HOX2, HOX2H"	ENSG00000173917	"Homeobox B2"	P14652	17	48540894-48544989	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 53.1"	"Cell line enhanced"	"Detected in many"		"AF22: 20.6;EFO-21: 19.9;HEK 293: 22.5;HMC-1: 45.0;WM-115: 19.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	6	"pons and medulla: 12.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	34	"pons and medulla: 4.7"	"Region enriched"	"Detected in single"	31	"pons and medulla: 5.4"	HPA047857			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047857: AB_2680184"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.89e-1)"	9.2	11.0	0.2	6.3	0.3	1.9	24.2	0.3	0.2	14.5	15.4	0.4	53.1	2.4	6.9	32.5	19.3	12.2	12.8	4.5	0.5	0.1	25.6	2.8	6.4	4.4	2.0	0.3	6.4	1.6	8.9	0.9	1.7	12.9	8.2	1.7	0.8	0.6	33.2	6.1	3.7	6.4	7.5	19.4	6.8	6.7	2.7	0.2	2.4	3.0	3.9	2.6	7.9	16.3	0.8	6.0	5.0	0.4	2.2	9.5	1.3	0.0	0.7	20.6	0.0	4.7	5.5	0.0	1.8	0.0	0.0	0.0	0.2	0.1	0.0	19.9	5.6	0.0	3.1	0.0	0.0	0.1	22.5	7.8	0.8	0.0	8.3	0.0	45.0	3.4	0.0	8.9	3.5	3.2	15.2	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	14.7	1.8	0.0	0.0	1.5	0.0	11.8	10.7	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	8.0	0.0	19.7	5.0	0.4	0.0	4.2	0.4	1.3	0.2	6.2	4.7	1.9	0.8	9.5	3.9	0.0	2.2	0.3	6.0	7.3	1.3	0.2	0.3	0.3	0.2	0.5	0.1	2.0	0.3	12.9	0.2
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.2;EFO-21: 17.7;HEK 293: 21.4;RPTEC TERT1: 16.6;U-251 MG: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	40	"pons and medulla: 9.3"	"Region enriched"	"Detected in single"	29	"pons and medulla: 12.9"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.45e-6)"	8.3	4.5	1.0	7.3	1.1	0.2	8.0	1.0	1.0	11.3	16.4	1.0	56.7	2.3	10.1	44.9	5.5	17.7	3.6	1.7	1.0	0.0	16.3	1.6	4.8	1.6	1.0	1.0	2.8	1.7	6.7	1.0	3.8	2.6	4.1	4.9	1.0	1.0	68.4	4.0	2.9	11.3	3.5	4.8	6.5	7.8	3.7	1.0	1.0	1.8	1.0	1.1	6.4	5.2	0.1	2.8	1.7	0.9	1.4	1.1	0.4	3.2	6.8	4.6	2.1	3.8	5.4	1.2	0.1	0.0	0.1	0.1	3.2	20.2	1.6	17.7	14.5	0.1	0.9	0.3	0.0	5.2	21.4	5.0	3.0	0.0	6.3	0.0	13.3	6.2	0.0	6.0	0.4	6.3	6.8	0.1	3.7	0.1	0.3	0.1	0.1	0.7	0.0	3.3	0.6	16.6	3.0	0.0	0.0	0.7	0.0	3.3	6.5	1.4	7.0	2.2	7.0	1.2	19.1	1.7	2.0	0.1	4.5	0.0	3.7	1.7	0.1	0.0	0.9	0.1	0.4	0.0	0.5	1.1	0.3	0.1	0.8	1.0	0.0	1.4	0.9	2.8	1.1	0.4	1.0	1.1	1.0	1.0	1.0	0.0	1.0	1.0	2.6	1.0
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593961	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 21.1;RPTEC TERT1: 15.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enriched"	"Detected in single"	33	"pons and medulla: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	90	"pons and medulla: 24.0"	"Region enriched"	"Detected in single"	100	"pons and medulla: 14.7"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favourable (8.59e-5)"	3.4	3.1	0.2	2.1	0.2	0.0	5.0	0.2	0.7	5.4	10.5	0.2	25.9	1.5	2.2	18.5	0.6	7.2	0.2	0.7	0.2	0.0	16.0	0.4	5.2	0.8	0.2	0.2	1.9	0.5	0.9	0.2	1.2	25.4	1.3	4.7	0.2	0.6	27.6	0.2	0.5	9.5	1.6	22.5	2.0	4.3	0.7	0.2	0.2	0.7	0.2	0.2	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.7	0.0	2.4	2.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.1	2.6	0.0	0.2	0.0	0.0	0.0	21.1	0.9	5.4	0.0	4.1	0.0	1.2	1.3	0.0	2.8	0.0	1.4	1.6	0.0	3.2	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	15.7	1.6	0.0	0.0	0.1	0.0	2.3	0.4	0.0	5.2	0.7	2.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	25.4	0.2
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 73.7;seminal vesicle: 56.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.1;HEK 293: 36.2;RPTEC TERT1: 24.6;TIME: 13.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.0"	"Region enriched"	"Detected in single"	60	"pons and medulla: 10.6"	"Region enriched"	"Detected in single"	62	"pons and medulla: 14.6"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA042063: "	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	5.2	4.3	0.3	18.1	0.3	0.0	3.8	0.3	0.3	12.0	8.5	0.3	73.7	0.5	7.2	30.5	0.4	8.7	0.3	0.3	0.3	0.0	26.6	0.4	3.4	0.3	0.3	0.3	0.6	0.6	1.9	0.3	1.5	0.9	4.3	3.8	0.3	0.3	56.7	1.0	0.6	8.2	1.8	10.0	1.7	5.9	1.8	0.3	0.3	0.3	0.3	0.3	4.2	10.0	1.5	0.2	0.0	0.0	0.0	1.0	0.3	2.3	5.4	0.0	2.8	2.5	2.7	0.0	0.0	0.0	0.0	0.0	2.9	3.5	0.0	13.1	6.4	0.0	0.6	0.2	0.0	0.1	36.2	3.2	9.0	0.0	3.8	0.2	8.4	3.2	0.1	5.2	0.1	2.4	2.0	0.0	7.2	0.1	0.0	0.1	0.0	2.1	0.0	6.1	0.3	24.6	1.1	0.0	0.0	1.9	0.0	3.5	0.9	1.1	13.6	0.5	2.8	2.2	10.0	0.0	0.0	0.0	0.4	0.0	4.4	0.0	0.0	0.0	0.7	0.0	0.2	1.4	0.4	1.0	0.2	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.9	0.3
HOXD8	"HOX4, HOX4E"	ENSG00000175879	"Homeobox D8"	P13378	2	176129694-176132695	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 37.6;epididymis: 42.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.2;RPTEC TERT1: 34.6;TIME: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"pons and medulla: 0.6"	"Not detected"	"Not detected"														"unprognostic (1.22e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (3.78e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.80e-2)"	11.1	9.1	0.3	2.4	0.3	0.0	9.8	0.2	0.4	10.3	5.9	0.4	37.6	0.3	12.6	42.6	2.0	7.7	2.5	2.6	0.3	0.0	32.8	0.2	0.7	1.9	0.2	0.2	16.9	1.7	0.2	0.2	1.4	1.2	5.6	1.8	0.3	0.8	27.5	6.9	2.4	4.2	5.3	11.5	9.1	0.8	21.0	0.2	0.3	2.9	2.3	0.9	5.3	10.8	0.2	0.0	0.0	0.0	0.0	0.2	0.0	6.3	1.0	0.0	0.0	4.3	6.7	0.1	0.8	3.3	1.0	0.1	0.0	0.0	0.0	8.1	4.8	0.0	2.1	0.2	2.5	0.0	3.1	1.0	0.3	0.0	1.4	0.6	0.4	11.7	21.2	0.1	3.2	10.5	0.1	0.0	1.6	0.0	0.0	0.1	0.1	1.2	0.0	2.2	0.0	34.6	4.3	6.8	12.7	1.9	0.0	12.6	0.0	0.0	15.1	0.5	4.4	7.2	4.3	0.0	0.0	0.0	10.1	0.0	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.3	0.0	0.2	0.2	1.2	0.2
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.7;WM-115: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA040092	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA040092: AB_10795374"	"prognostic favourable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favourable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.2	2.2	0.7	1.2	3.4	6.3	0.0	15.1	13.5	19.0	12.7	8.8	30.1	0.0	1.1	9.7	3.2	0.0	15.9	7.8	4.2	6.2	2.8	7.9	0.0	22.4	0.0	0.0	3.7	4.6	21.5	0.0	38.7	0.2	0.0	12.7	0.3	2.5	2.9	3.2	4.4	13.3	0.0	0.1	13.2	0.6	8.2	6.1	16.8	9.5	3.7	2.4	21.6	17.8	1.2	0.0	3.4	29.3	0.0	0.0	0.0	1.0	4.0	32.8	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1
ILDR1	"DFNB42, MGC50831"	ENSG00000145103	"Immunoglobulin like domain containing receptor 1"	Q86SU0	3	121987323-122022258	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.9;seminal vesicle: 27.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.5;HDLM-2: 9.6;MCF7: 5.9;RT4: 8.9;T-47d: 6.4;U-266/70: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018207	Approved				"Intracellular and membrane"					"HPA018207: AB_1851742"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.46e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.37e-1)"	"prognostic favourable (5.79e-9)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.21e-2)"	0.3	1.5	0.3	0.7	0.4	0.0	1.8	0.3	0.3	8.6	5.6	0.3	28.9	2.0	1.6	17.2	5.9	3.4	4.7	0.3	0.3	0.2	8.0	0.4	2.9	0.3	0.3	0.3	0.9	16.5	14.8	4.1	2.6	0.4	4.9	5.0	1.3	10.6	27.8	0.3	1.7	2.4	0.3	0.3	1.1	0.3	1.5	0.3	0.9	5.1	1.9	3.7	5.6	1.6	5.1	0.5	1.5	0.7	0.1	1.0	0.4	3.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	7.5	1.3	0.1	0.0	1.2	0.0	0.0	0.0	9.6	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.0	0.1	0.1	0.0	0.0	0.1	2.7	3.4	8.9	0.3	0.1	0.0	0.9	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.1	7.4	1.6	1.3	0.0	0.2	0.1	0.6	0.7	0.1	0.2	0.4	0.2	5.1	0.2	0.3	0.5	3.4	0.4	0.3	1.5	0.1	0.2	0.4	1.0	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3
IRF5		ENSG00000128604	"Interferon regulatory factor 5"	Q13568	7	128937612-128950035	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 45.1;RPMI-8226: 32.7;THP-1: 18.2;U-937: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"B-cells: 8.9;dendritic cells: 20.6;monocytes: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046700	Enhanced									"HPA046700: AB_2679761"	"unprognostic (4.01e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.20e-3)"	5.4	3.6	6.2	10.1	8.4	16.8	8.8	2.0	5.0	2.7	3.5	5.6	40.1	8.0	1.6	2.5	12.0	4.1	5.3	12.3	7.3	5.2	12.6	5.1	15.8	18.9	12.3	2.2	1.4	7.0	10.2	5.7	3.4	7.5	3.3	2.9	2.0	6.3	24.0	1.1	7.1	10.0	2.5	7.0	25.5	3.6	1.6	8.4	3.9	2.2	1.6	9.9	6.8	5.1	8.9	20.6	1.8	24.2	2.0	2.7	8.5	5.7	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.1	2.3	4.0	2.0	0.0	5.0	1.2	0.9	0.1	45.1	1.2	6.3	0.0	0.7	0.0	0.9	9.1	0.0	5.8	0.2	0.6	0.0	0.0	12.3	0.0	1.8	0.0	1.9	0.1	1.0	0.3	0.0	32.7	1.7	2.8	0.1	0.7	1.0	1.0	0.5	1.7	18.2	0.0	0.0	0.1	0.1	0.4	7.1	4.7	1.6	0.2	22.4	0.1	0.8	19.0	1.8	0.5	24.2	1.9	8.9	1.1	0.4	20.6	6.8	0.0	0.0	1.3	2.0	17.1	4.9	2.7	8.5	6.2	8.4	2.0	5.0	7.3	5.2	12.3	2.2	7.5	8.4
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023129	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.8;endometrium 1: 48.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.3;U-138 MG: 20.0;WM-115: 16.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	27	"naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	87	"B-cells: 10.8"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7"	"Group enriched"	"Detected in all"	4	"amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1"	"HPA039530, HPA040024"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.19e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.83e-9)"	"unprognostic (1.52e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-2)"	0.5	4.5	13.3	2.9	7.0	0.3	0.7	2.3	11.9	9.6	2.4	1.6	25.8	0.6	48.3	2.8	3.7	11.9	1.9	1.0	7.9	2.9	0.5	0.4	0.5	3.0	2.0	9.5	0.9	3.7	1.3	0.8	9.3	6.7	5.6	1.3	0.7	1.4	18.3	0.3	0.5	7.2	5.8	1.0	3.5	0.8	5.4	2.6	0.0	0.5	0.0	1.4	2.8	3.4	10.8	0.0	0.0	0.1	0.0	0.0	0.1	0.4	1.7	1.3	6.4	0.7	1.7	0.1	5.6	0.0	3.3	2.6	0.1	0.1	0.0	3.5	1.6	1.6	0.8	1.6	3.4	0.2	2.1	0.0	6.2	0.0	11.7	0.0	0.2	3.4	26.3	12.6	12.9	0.8	0.1	0.0	0.3	6.3	0.0	0.1	6.7	11.6	0.0	0.0	0.0	0.0	1.9	1.9	7.3	12.2	14.3	9.2	1.0	0.9	0.3	20.0	11.8	0.1	1.6	0.0	0.0	0.0	5.9	0.4	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.3	7.0	2.3	11.9	7.9	2.9	2.0	9.5	6.7	2.6
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium voltage-gated channel subfamily J member 5"	P48544	11	128891356-128921035	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4"	"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Enhanced									"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.8	40.7	0.8	0.3	1.9	0.2	0.9	0.3	1.2	0.8	0.8	1.9	54.6	0.4	0.3	1.1	0.6	0.6	1.3	8.7	1.6	2.5	2.0	0.3	3.4	0.8	3.7	0.8	0.8	16.6	0.7	23.4	4.3	3.4	0.8	0.4	3.3	0.9	21.7	0.3	0.4	0.5	0.7	4.5	7.7	1.5	0.7	0.9	2.3	0.7	0.4	0.3	1.1	0.5	0.9	0.4	2.9	0.7	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	17.1	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.2	0.1	0.1	1.3	0.0	2.2	0.7	0.6	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.9	0.3	0.4	2.9	0.6	0.4	0.4	0.2	0.4	0.8	1.9	0.3	1.2	1.6	2.5	3.7	0.8	3.4	0.9
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745780-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.2"	"Cell line enriched"	"Detected in some"	8	"MCF7: 31.4"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"olfactory region: 8.4"	"Region enriched"	"Detected in single"	8	"olfactory region: 9.3"	HPA064861	Uncertain									"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	6.0	4.5	0.4	1.3	3.4	0.5	5.9	0.0	1.2	6.2	2.3	0.0	24.2	1.1	4.3	10.6	3.2	15.1	10.7	3.8	0.6	0.4	3.5	7.0	3.0	2.2	0.6	0.0	12.6	7.4	0.6	4.2	1.1	1.1	2.7	0.8	2.1	3.4	9.6	2.6	2.0	0.9	3.8	0.3	0.6	4.1	10.6	0.0	0.0	6.5	0.5	0.9	2.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	0.9	0.4	3.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	0.0	1.2	0.6	0.4	0.6	0.0	1.1	0.0
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849110	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.3;RPMI-8226: 15.0;U-266/70: 8.9;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553"	Enhanced									"CAB018656: AB_2131551, HPA048553: AB_2680438"	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favourable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	3.0	78.2	1.0	5.1	1.0	3.4	3.1	0.6	1.2	5.0	13.7	4.1	88.1	14.2	1.9	15.9	1.5	2.1	12.2	10.7	1.5	1.0	13.8	1.0	11.4	5.8	1.2	0.8	1.6	25.6	5.6	2.7	1.8	1.8	7.5	4.6	2.5	9.5	83.6	0.8	1.0	18.4	1.5	1.4	5.5	31.2	3.6	1.5	1.6	36.2	0.9	4.8	5.5	3.6	1.2	5.6	5.3	4.7	0.0	1.7	1.4	0.0	0.1	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.6	1.0	3.7	0.0	0.1	0.5	0.0	0.0	0.2	1.0	0.0	2.6	0.3	0.2	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.8	0.2	0.1	0.0	15.0	5.6	1.8	0.5	4.1	0.5	0.0	0.0	0.1	5.7	0.0	0.0	0.2	0.1	0.0	8.9	0.0	0.0	0.0	8.8	0.0	1.6	4.7	4.7	0.0	2.6	0.1	1.2	0.6	0.1	5.6	0.6	1.7	1.7	5.3	0.0	3.7	1.9	0.5	1.4	1.0	1.0	0.6	1.2	1.5	1.0	1.2	0.8	1.8	1.5
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.96e-5)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.0	0.3	0.3	0.8	0.4	2.1	1.1	0.9	2.0	5.0	7.8	5.1	0.0	5.6	0.6	0.6	0.3	15.1	5.3	0.2	7.7	0.0	1.8	16.5	3.0	0.1	0.0	2.4	0.4	8.2	6.5	0.5	0.1	0.0	0.8	0.1	0.2	0.4	3.8	0.3	0.2	0.0	0.0	26.8	2.0	1.3	0.1	0.0	0.1	2.5	0.8	0.6	0.4	0.1	12.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8
KIAA1549		ENSG00000122778	KIAA1549	Q9HCM3	7	138831381-138981318	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 27.5;seminal vesicle: 39.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 20.0;SH-SY5Y: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019560	Uncertain		Approved	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane"	"Nuclear membrane"	"HPA019560: AB_1852418"	"unprognostic (7.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.30e-2)"	"prognostic favourable (3.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.28e-2)"	2.1	3.2	3.3	0.6	4.4	0.6	2.9	1.2	8.3	2.7	1.8	1.6	27.5	1.5	3.7	4.1	1.4	4.9	2.5	1.9	3.1	2.0	8.0	1.5	4.7	0.3	1.6	3.8	2.6	12.9	6.5	3.6	4.6	3.7	3.1	1.5	2.0	4.4	39.0	1.4	2.6	1.8	2.9	3.3	1.2	3.0	2.9	1.2	3.1	2.2	0.1	0.4	3.8	4.4	0.3	0.1	1.5	0.1	0.3	0.2	0.0	5.0	9.5	8.4	14.8	0.1	0.0	4.9	5.1	4.6	3.0	3.8	8.9	3.1	0.0	3.2	7.8	1.0	5.3	1.5	3.6	2.4	3.2	2.4	10.3	2.2	1.3	3.6	3.4	1.2	2.3	1.1	1.6	4.9	1.9	0.1	3.3	4.7	2.6	3.5	8.0	20.0	7.1	4.3	0.0	1.5	3.1	11.2	19.2	2.7	5.1	2.2	4.2	2.2	3.1	3.0	3.1	0.0	4.8	0.7	0.0	0.2	4.0	1.4	7.1	1.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.5	0.3	0.1	0.1	0.0	0.0	3.3	4.4	1.2	8.3	3.1	2.0	1.6	3.8	3.7	1.2
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672671-32773062	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 14.6;seminal vesicle: 19.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;Hep G2: 16.4;REH: 4.4;RPTEC TERT1: 9.1;SCLC-21H: 3.5;U-698: 4.8"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	97	"memory B-cell: 10.7;naive B-cell: 8.5"	"Lineage enriched"	"Detected in single"	108	"B-cells: 10.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"hippocampal formation: 22.7;olfactory region: 20.4"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"				Cytosol	Cytosol	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.6	0.1	0.4	1.0	0.4	1.5	0.6	0.4	1.0	2.4	0.4	0.4	14.6	0.0	1.5	1.4	0.4	6.3	0.4	0.4	0.4	0.3	4.3	0.4	0.4	5.1	0.4	0.4	1.1	0.4	10.3	1.1	0.4	1.5	1.6	0.0	1.0	0.4	19.3	0.4	0.1	2.3	0.4	0.4	9.5	0.1	2.8	0.4	0.4	11.7	0.4	3.8	0.4	0.7	10.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	16.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	4.4	1.4	0.0	9.1	0.0	3.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	1.0	0.4	0.3	0.4	0.4	1.5	0.4
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.5;epididymis: 9.7;testis: 22.0"	"Cell line enhanced"	"Detected in some"		"THP-1: 3.4;WM-115: 1.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.0"												"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	1.7	0.0	0.4	0.0	2.4	2.7	0.4	0.1	1.9	0.0	0.1	0.2	15.5	0.0	0.0	9.7	0.1	1.7	0.1	0.5	0.2	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.4	4.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.0	0.7	0.1	22.0	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.4	2.4	0.1	1.9	0.2	0.1	0.0	0.0	0.0	1.1
MARCOL		ENSG00000248109	"MARCO like"		5	148221650-148243580	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.8;epididymis: 5.7;seminal vesicle: 3.1;skeletal muscle: 2.9"	"Cell line enriched"	"Detected in some"	8	"HeLa: 124.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.3	0.0	3.8	0.0	0.7	5.7	0.0	0.0	0.0	0.9	0.0		1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.1	2.9	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0										
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.5;THP-1: 58.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	Cytosol	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.4	6.6	3.1	0.6	0.0	2.0	3.9	4.5	5.4	0.2	1.1	13.0	1.2	1.0	5.2	4.3	7.5	3.5	1.6	2.1	1.5	0.0	0.0	10.5	2.3	7.7	3.5	4.7	18.5	7.6	1.1	0.0	3.3	2.0	0.2	3.5	3.5	3.5	1.6	2.5	6.5	3.0	0.7	6.1	1.6	2.4	1.5	11.1	1.1	0.5	58.2	0.7	1.0	1.9	3.3	8.5	0.6	1.1	2.9	10.4	8.8	3.2	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3
MUC6		ENSG00000184956	"Mucin 6, oligomeric mucus/gel-forming"	Q6W4X9	11	1012821-1036706	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 426.4;seminal vesicle: 478.2"	"Cell line enhanced"	"Detected in single"		"A549: 2.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 58.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	14	"basal ganglia: 20.1"	CAB002165	Enhanced				"Secreted to digestive system"					"CAB002165: AB_442114"	"unprognostic (1.90e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.23e-2)"	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.4	5.3	0.1	0.3	426.4	13.1	0.5	3.1	2.1	0.5	118.1	0.1	0.0	0.0	0.4	1.3	0.1	0.1	0.0	0.0	0.1	36.5	0.1	0.0	0.1	0.0	5.2	0.1	0.0	0.1	478.2	0.2	0.2	0.1	0.1	0.0	0.2	76.6	0.2	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.5	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117077-104138289	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 107.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004211	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004211: AB_628018"	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavourable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	16.1	23.4	22.2	13.9	21.3	10.8	17.5	18.5	17.5	16.1	28.2	13.6	107.1	9.9	16.8	25.8	13.7	16.0	13.7	20.0	22.6	16.9	15.4	21.8	16.0	17.4	21.9	12.4	15.9	11.3	17.3	19.0	16.3	15.6	23.5	14.4	10.1	10.3	53.7	18.5	11.2	10.6	20.0	24.9	10.1	13.8	13.7	20.4	21.4	19.2	13.5	18.5	20.2	27.9	15.6	7.4	22.8	10.2	15.1	21.1	10.7	13.6	11.8	22.5	13.7	15.2	16.5	21.2	13.7	11.3	15.2	10.4	8.8	6.4	18.3	6.7	12.2	9.1	18.0	8.7	16.5	12.5	5.7	11.1	13.2	8.0	16.0	15.8	7.7	23.9	11.9	6.1	11.9	9.8	10.7	7.4	12.6	15.5	19.9	15.8	21.2	12.8	18.6	13.0	8.0	10.7	13.9	13.5	11.1	24.0	59.9	7.7	22.4	16.2	7.3	8.9	6.1	8.0	9.8	14.3	12.2	20.4	5.6	9.7	9.2	17.3	7.5	22.8	16.3	9.5	21.1	15.6	15.7	17.1	7.4	11.3	17.5	17.4	10.5	15.1	10.2	6.8	20.5	10.7	22.2	21.3	18.5	17.5	22.6	16.9	21.9	12.4	15.6	20.4
NKX2-6	"CSX2, NKX4-2"	ENSG00000180053	"NK2 homeobox 6"	A6NCS4	8	23702451-23706598	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.4;heart muscle: 2.7;lymphoid tissue: 3.0;salivary gland: 4.3"	"Group enriched"	"Detected in some"	8	"hTEC/SVTERT24-B: 8.9;LHCN-M2: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (1.86e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874345	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0"	"Cell line enriched"	"Detected in some"	21	"CACO-2: 25.9"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 1.8"												"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favourable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.1	0.1	0.2	8.8	0.2	0.0	0.1	0.2	0.2	0.2	28.3	0.0	15.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	36.3	0.0	0.1	18.0	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0.0	0.4	0.1	0.0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.4	0.9	0.4	0.3	0.2	0.0	0.3	0.3	0.0	0.0	0.0	25.9	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	1.1	1.0	0.7	0.9	0.6	0.6	0.4	0.0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.1;HAP1: 11.4;HEK 293: 8.4;NTERA-2: 20.9;SH-SY5Y: 4.6;U-2 OS: 10.5"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"											"HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735603-100829941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1"	"Group enriched"	"Detected in some"	9	"AN3-CA: 14.2;EFO-21: 19.8;RPTEC TERT1: 14.1"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 1.0;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 1.5;pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 7.9;pons and medulla: 8.1"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"			Nucleoli	Nucleoli	"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: "	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.1	3.1	0.1	0.0	30.5	0.0	1.5	93.7	0.1	9.1	0.0	0.1	0.1	0.1	43.1	0.1	0.1	0.0	0.2	0.0	1.5	0.3	0.6	0.7	0.0	1.8	0.8	0.0	0.5	0.1	19.4	0.1	0.1	0.1	0.0	1.7	0.1	0.1	2.4	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	14.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.1	0.1	0.1	0.2	0.0	1.8	0.1
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.6	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.4	0.2	0.9	0.2	0.2	0.5	0.7	2.7	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.7	0.3	0.9	0.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Group enriched"	"Detected in some"	5	"BEWO: 2.9;HaCaT: 4.6;hTERT-HME1: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	8.5	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell line enhanced"	"Detected in many"		"A549: 16.7;HeLa: 24.3;RPMI-8226: 30.2;U-2197: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Cytosol		78000	78000	Cytosol	Cytosol	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: "	"prognostic favourable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	16.7	0.0	0.0	10.5	4.2	0.0	0.6	6.4	0.8	1.4	0.1	6.6	0.0	0.0	0.0	1.2	10.4	3.1	0.3	5.1	0.2	3.1	24.3	0.0	6.5	4.5	1.6	2.3	2.2	8.4	1.7	7.0	6.8	2.5	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	30.2	0.0	2.3	0.1	0.0	2.5	0.8	2.9	0.3	6.2	1.4	6.2	0.8	28.5	1.3	1.0	0.0	0.0	2.3	13.6	8.8	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3
RASL10B	"RRP17, VTS58635"	ENSG00000270885	"RAS like family 10 member B"	Q96S79	17	35731649-35743521	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.6;skeletal muscle: 26.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.0;HHSteC: 16.0;HSkMC: 11.6;NTERA-2: 23.9;REH: 11.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046842, HPA057092"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA046842: AB_2679835, HPA057092: AB_2683332"	"unprognostic (5.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (6.38e-6)"	"unprognostic (8.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-6)"	"unprognostic (2.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.60e-3)"	12.8	0.9	6.3	0.3	9.1	0.2	2.8	0.3	12.3	1.8	0.3	1.0	24.6	0.8	1.3	0.8	0.3	3.9	0.8	10.9	4.7		1.0	1.1	0.4	0.2	0.0	2.8	2.5	4.7	2.5	1.1	2.8	6.3	0.9	0.2	1.1	12.6	15.2	26.7	0.3	0.9	0.9	0.6	0.2	0.3	1.6	2.5	0.0	0.9	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	3.6	0.0	0.6	0.4	1.0	0.6	0.4	2.5	2.1	4.5	0.0	0.0	0.4	0.1	0.0	14.0	0.0	0.8	0.0	4.6	0.0	2.3	5.2	16.0	0.0	0.0	11.6	0.9	0.8	0.0	0.0	3.0	0.0	0.2	0.2	6.3	0.0	23.9	0.0	11.6	6.4	10.4	0.0	0.0	10.7	10.4	0.7	0.2	0.9	1.3	0.7	0.0	1.2	8.6	0.0	0.3	0.0	0.0	2.8	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 10.8;PC-3: 11.7;RH-30: 14.4;SH-SY5Y: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.6	3.5	0.0	3.4	3.4	0.0	7.5	4.0	3.4	2.8	2.7	3.0	0.0	0.0	4.1	0.1	9.0	6.0	7.9	0.0	4.5	0.0	0.1	0.0	3.0	0.0	0.0	1.9	0.0	0.0	3.7	0.8	0.0	0.1	2.7	0.0	1.3	0.1	10.8	11.7	0.0	14.4	0.0	0.5	8.3	0.0	11.5	0.0	4.2	0.0	1.9	0.0	0.0	0.1	4.3	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593120	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 74.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056919			Approved	Mitochondria	"Secreted to blood"	2300000000	2300000000	Mitochondria	Mitochondria	"HPA056919: AB_2797257"	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	1.1	100.4	0.4	1.8	1.8	0.0	7.7	0.2	0.5	4.0	1.0	1.6	126.6	0.6	4.8	5.0	0.5	3.6	34.3	5.6	0.6	0.4	33.6	112.4	0.3	1.9	3.1	0.3	6.4	33.8	0.0	0.8	0.2	1.9	1.9	0.0	0.9	10.9	106.7	6.6	0.7	0.7	0.4	1.5	36.1	2.0	146.5	0.6	0.1	0.9	1.5	0.6	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.1	5.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.2	0.5	0.6	0.4	3.1	0.3	1.9	0.6
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.8;BJ: 12.5;BJ hTERT+: 18.3;RPTEC TERT1: 14.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA024385: "	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favourable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	7.8	0.0	12.5	18.3	5.6	5.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	5.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0
SLC15A2	PEPT2	ENSG00000163406	"Solute carrier family 15 member 2"	Q16348	3	121894089-121944102	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.2;ductus deferens: 35.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.2;U-937: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.72e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (3.50e-2)"	"prognostic favourable (6.96e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.03e-3)"	"prognostic favourable (6.74e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.60e-2)"	1.0	1.2	13.8	1.9	15.0	3.3	3.2	4.0	15.3	35.2	1.8	7.6	35.8	1.5	1.5	26.2	3.6	7.4	4.2	2.0	14.6	5.3	7.4	1.1	12.9	3.6	5.3	12.9	1.0	3.6	2.4	3.6	1.6	6.8	26.5	2.1	15.1	14.6	25.1	0.8	0.7	2.2	0.9	4.0	6.1	1.1	3.9	6.7	0.0	4.6	0.5	3.8	3.6	2.6	4.2	1.6	2.4	2.5	0.3	0.3	0.3	1.8	0.9	1.1	0.4	1.3	0.7	1.4	0.2	0.1	0.5	0.6	1.7	3.2	3.4	0.2	0.1	2.0	0.8	1.8	0.6	2.7	0.6	4.9	1.3	0.8	0.2	5.1	4.9	1.0	5.4	0.5	0.4	0.3	0.7	1.5	0.6	1.4	1.0	8.2	5.6	0.5	1.2	0.5	1.0	1.2	1.2	0.4	0.4	0.5	0.3	0.1	0.3	4.6	0.1	0.4	0.3	0.4	0.4	1.8	0.5	4.9	0.5	7.0	0.5	2.4	1.1	0.4	0.3	0.4	0.3	3.3	0.3	0.2	0.3	4.2	0.3	0.3	0.6	0.3	2.5	1.6	0.2	0.3	13.8	15.0	4.0	11.0	14.6	5.3	5.3	12.9	6.8	6.7
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved									"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favourable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.4	0.0	0.1	3.6	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8"	"Cell line enriched"	"Detected in single"	70	"HaCaT: 22.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"				"Plasma membrane"	"Plasma membrane"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	1.3	0.3	0.4	5.6	1.2	0.0	44.3	0.0	0.8	0.0	13.0	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.2	1.0	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.3	0.1	6.1	3.3	1.2	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	22.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.4	0.0	0.2	0.1	0.2	0.0
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890913	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.1;U-2197: 1.0"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 17.0;intermediate monocyte: 8.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved									"HPA020098: AB_2670363"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.2	0.1	0.1	0.5	0.1	0.0	1.0	1.1	0.5	17.7	0.1	0.0	21.1	0.0	3.6	10.4	1.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	17.1	1.9	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.8	0.0	0.1	0.4	9.9	0.1	22.3	0.2	0.6	0.2	1.0	0.1	1.5	0.0	31.8	0.1	0.0	0.3	5.4	0.7	0.0	3.8	0.2	17.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	6.5	0.1	0.0	4.1	0.1	0.1	1.1	0.5	0.1	0.3	0.1	0.2	0.0	0.0
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932696-134052184	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 112.9;seminal vesicle: 147.1"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA013742	Enhanced									"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favourable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	9.3	14.7	1.0	6.0	1.0	0.0	6.2	0.4	1.6	13.9	8.1	1.5	112.9	3.7	18.4	4.5	7.8	11.5	15.3	10.1	0.7	0.5	32.9	4.2	56.8	10.6	0.7	1.2	7.2	9.2	16.1	6.5	40.3	1.8	13.7	7.2	15.1	8.2	147.1	1.5	4.5	10.1	13.6	3.0	17.7	8.3	3.0	0.6	4.6	33.6	8.6	9.0	10.5	7.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	2.0	0.2	0.0	0.0	0.0	0.0	44.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	10.3	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	1.0	0.4	1.6	0.7	0.5	0.7	1.2	1.8	0.6
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Cell line enriched"	"Detected in some"	5	"BEWO: 44.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"				Nucleoplasm	Nucleoplasm	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.4	0.0	0.0	0.0	0.0	44.6	0.2	0.2	0.9	0.2	9.4	0.9	0.0	0.3	0.0	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	5.6	1.4	0.0	0.0	5.7	0.0	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210536-39225872	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 94.0;seminal vesicle: 101.5"	"Group enriched"	"Detected in some"	5	"HeLa: 25.6;U-87 MG: 11.7"	"Group enriched"	"Detected in many"	7	"breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavourable (4.05e-5)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	2.4	0.9	4.2	1.0	7.4	0.7	29.7	9.5	21.9	4.0	0.9	0.0	94.0	0.9	2.5	13.9	0.8	1.4	0.8	1.0	6.8	3.2	4.8	0.7	0.9	0.8	3.5	6.6	1.2	1.1	0.7	0.5	1.0	13.1	1.8	0.9	8.2	7.8	101.5	0.8	20.1	0.8	1.7	1.4	0.8	0.8	0.9	0.2	0.0	0.7	0.0	0.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	7.4	9.5	21.7	6.8	3.2	3.5	6.6	13.1	0.2
TMEM229B	"C14orf83, FLJ33387"	ENSG00000198133	"Transmembrane protein 229B"	Q8NBD8	14	67447084-67533739	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.8;ductus deferens: 27.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.1;MCF7: 9.5;SK-MEL-30: 8.1;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046562	Approved									"HPA046562: AB_10960265"	"prognostic favourable (5.38e-4)"	"unprognostic (6.55e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.21e-5)"	"unprognostic (7.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-2)"	"prognostic favourable (1.79e-5)"	1.6	14.5	9.4	5.2	7.1	1.6	3.8	27.8	11.5	11.8	5.9	2.7	27.5	15.9	1.5	11.9	1.3	2.2	4.2	1.7	10.6	7.9	2.2	1.5	3.5	8.3	9.0	5.7	1.2	5.7	5.8	8.1	7.7	13.3	2.9	3.4	5.1	4.1	11.8	0.6	1.4	14.1	3.3	6.5	9.4	4.2	5.6	2.0	8.9	9.7	0.0	6.1	5.9	1.7	1.2	2.8	8.7	6.9	5.5	11.0	5.0	2.2	0.3	0.0	0.6	0.2	0.0	0.9	0.4	0.5	0.6	2.4	0.0	7.2	9.1	0.0	0.2	0.0	0.2	0.5	0.1	2.9	0.7	5.5	0.0	0.0	0.8	5.9	1.1	0.1	0.3	0.1	0.0	0.0	0.1	0.3	0.0	9.5	3.5	2.2	0.1	0.4	3.3	0.1	1.3	0.1	4.8	1.4	0.3	0.0	3.5	8.1	7.5	5.7	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.4	24.3	5.1	6.0	5.1	8.7	11.0	6.7	10.6	1.2	6.5	8.7	2.8	1.1	5.7	7.1	0.1	5.5	6.9	1.6	2.6	5.0	9.4	7.1	27.8	11.5	10.6	7.9	9.0	5.7	13.3	2.0
TMEM238L	LINC00675	ENSG00000263429	"Transmembrane protein 238 like"		17	10794913-10804099	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ductus deferens: 19.9;intestine: 19.0;seminal vesicle: 14.6;stomach 1: 23.0"	"Cell line enriched"	"Detected in some"	8	"RT4: 9.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (7.23e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.30e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.19e-2)"	0.0	0.0	0.2	7.5	0.6	0.0	0.6	0.0	1.0	0.0	18.3	0.0	19.9	8.8	0.0	1.1	3.2	0.0	9.5	0.0	0.4		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	19.0	0.0	0.0	14.6	0.0	0.2	14.0	1.2	0.0	0.0	23.0	0.0	0.0	0.0	0.0	2.8	3.1	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TTC23L	FLJ25439	ENSG00000205838	"Tetratricopeptide repeat domain 23 like"	Q6PF05	5	34838833-34899456	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 13.5;testis: 25.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 2.4;NTERA-2: 1.9;T-47d: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037807	Enhanced									"HPA037807: AB_10672466"	"unprognostic (7.87e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-3)"	"unprognostic (8.92e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.16e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.53e-3)"	"unprognostic (4.69e-4)"	0.4	1.0	1.8	0.4	5.3	0.2	1.1	0.4	1.7	0.9	0.4	1.6	13.5	0.2	0.7	3.1	0.4	4.9	0.5	0.4	3.3	1.0	0.6	0.5	0.6	0.5	0.6	1.6	0.5	1.2	2.1	8.6	0.3	3.0	0.5	0.3	1.0	1.0	10.0	0.4	1.0	0.4	0.3	1.1	0.4	0.5	25.9	1.2	0.0	1.0	0.0	0.4	0.6	0.4	1.4	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.4	0.6	0.6	0.0	0.0	1.3	0.1	0.0	0.4	0.1	0.0	1.7	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.5	0.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.4	0.1	1.9	0.3	0.4	0.3	0.0	0.2	0.2	1.8	0.4	0.6	1.1	0.8	2.2	0.0	0.0	0.3	1.6	0.4	0.1	1.8	0.8	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.2	0.0	1.4	0.5	0.7	0.0	0.2	0.0	0.0	0.0	0.2	1.8	5.3	0.4	1.7	3.3	1.0	0.6	1.6	3.0	1.2
WFDC12	"C20orf122, dJ211D12.4, WAP2"	ENSG00000168703	"WAP four-disulfide core domain 12"	Q8WWY7	20	45123425-45124465	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 26.9;skin 1: 30.5"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"head and neck cancer: 18.9;melanoma: 14.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																"Secreted - unknown location"	20000	20000					"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-2)"		"unprognostic (5.42e-2)"		"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.70e-3)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (4.49e-2)"		"unprognostic (3.91e-1)"	"unprognostic (5.50e-3)"	0.1	0.0	0.1	0.1	0.1	0.5	1.9	0.1	0.1	1.5	0.1	0.1	26.9	0.2	0.1	1.2	6.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	3.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	1.3	0.0	0.1	1.8	4.1	0.2	30.5	0.1	0.1	0.1	0.1	0.0	1.0	0.1	2.2	0.1	6.4	0.9	0.1	10.0	0.8	0.3	0.9	0.4	0.0	1.1	0.0	0.8	0.6	0.3	0.5	3.4	0.4	1.3	0.3	1.7	0.2	1.6	0.6	0.4	0.8	0.3	0.4	0.6	0.3	0.9	2.3	1.5	0.0	0.0	1.1	1.2	1.3	0.0	1.3	0.0	0.3	1.4	0.9	1.0	0.9	1.2	1.1	0.4	0.4	1.3	1.6	0.4	0.3	1.9	0.4	2.1	0.5	0.0	0.2	0.0	1.0	0.0	0.6	2.5	0.0	0.2	0.4	1.2	1.2	1.3	1.3	1.3	0.9	3.2	0.6	0.1	0.4	0.9	0.1	0.4	1.1	0.3	0.1	0.2	0.1	0.8	0.4	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.1;HEK 293: 9.8;hTEC/SVTERT24-B: 2.9;U-2197: 4.7;U-266/70: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	125	"memory B-cell: 13.1;naive B-cell: 11.8"	"Lineage enriched"	"Detected in single"	132	"B-cells: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.3	0.5	0.8	0.7	1.0	0.2	2.0	0.9	2.2	19.7	1.0	0.2	11.7	0.2	2.1	7.9	0.3	0.4	0.3	0.2	0.8	0.4	0.2	0.4	0.4	1.3	0.8	0.9	0.1	0.2	0.1	0.6	0.8	1.6	1.0	0.3	0.0	0.5	4.0	0.3	24.4	0.7	0.3	2.3	1.2	0.3	0.6	0.8	0.0	0.2	0.0	0.6	0.5	5.5	13.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.3	4.1	0.3	0.0	0.9	1.0	0.0	0.0	0.1	0.0	9.8	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.5	2.9	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	0.9	2.2	0.8	0.4	0.8	0.9	1.6	0.8
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"thalamus: 6.4"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"					"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	1.0	0.4	0.3	0.2	0.4	0.3	0.8	1.4	1.6	0.4	0.5	0.1	31.6	1.5	0.8	13.0	0.2	0.6	0.2	2.1	1.1	1.0	7.4	2.4	2.4	0.5	1.0	0.0	0.3	0.3	4.2	0.1	0.5	2.0	0.5	0.2	6.7	0.2	19.1	0.6	2.5	4.5	0.4	0.7	1.8	0.2	0.9	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.6	0.5	2.0	0.5	0.3	0.4	0.0	0.1	0.5	3.1	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.4	0.7	0.2	0.4	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.3	0.2	0.3	0.1	0.2	0.5	0.1	0.0	0.4	0.0	0.7	0.2	0.6	0.0	1.0	0.1	0.1	0.0	2.0	0.3	0.3	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.4	0.4	1.8	0.3	0.5	0.5	0.2	0.0	0.3	0.4	1.4	1.6	1.1	1.0	1.0	0.0	2.0	0.0
WWC3	"BM042, KIAA1280"	ENSG00000047644	"WWC family member 3"	Q9ULE0	X	10015562-10144478	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 56.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039814	Uncertain		Approved	"Actin filaments,Cytosol"				Cytosol	Cytosol	"HPA039814: AB_10674987"	"unprognostic (2.53e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (9.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.50e-2)"	10.2	13.2	8.9	9.8	12.6	5.3	10.3	13.7	10.1	10.0	13.1	18.2	56.9	4.5	11.6	22.0	12.4	8.9	10.8	15.4	10.0	7.2	7.2	3.9	21.0	12.5	13.1	6.4	18.7	9.4	9.9	6.7	25.7	10.6	11.3	5.6	12.6	9.0	44.4	7.6	12.3	10.8	13.2	9.4	11.8	11.2	6.9	11.8	6.2	12.2	8.1	10.2	10.2	18.1	6.6	0.7	12.3	1.0	2.7	6.9	2.1	6.7	7.7	9.4	3.1	3.9	5.6	8.9	3.8	6.7	2.3	2.6	1.0	7.1	0.7	0.0	5.1	3.5	2.1	4.0	1.9	5.0	0.7	1.5	5.0	0.7	8.5	0.0	2.4	3.6	8.4	5.8	6.2	10.9	0.1	9.2	5.6	13.9	1.6	0.4	8.8	2.7	4.9	0.4	2.9	2.2	3.5	1.0	2.6	4.7	6.1	4.1	53.9	0.5	14.5	6.8	0.1	10.0	4.2	7.5	5.0	2.5	4.1	2.5	10.0	4.1	1.0	0.2	6.9	0.8	6.0	2.4	3.4	5.1	0.5	6.6	3.2	3.8	12.3	2.7	0.8	0.7	1.6	2.1	8.9	12.6	13.7	10.1	10.0	7.2	13.1	6.4	10.6	11.8
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.3;seminal vesicle: 36.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.7;HBF TERT88: 6.5;NTERA-2: 16.5;U-2197: 6.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"											HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	1.5	1.0	1.1	3.6	2.5	1.6	1.8	6.9	1.1	3.0	1.7	1.2	20.3	0.5	3.3	2.7	2.1	2.8	1.0	1.4	0.8	0.6	1.7	0.7	2.4	3.0	2.1	0.3	4.7	3.4	12.7	1.4	3.8	1.7	4.1	2.1	3.2	1.2	36.4	1.2	2.8	2.3	3.3	1.6	2.3	2.7	1.6	2.2	4.1	10.3	0.7	2.9	4.9	2.9	0.5	0.4	1.8	0.2	0.3	0.9	0.2	0.0	0.0	3.9	9.7	0.0	0.0	0.0	1.0	0.4	3.8	4.5	3.3	2.3	1.4	1.8	0.7	1.0	0.0	0.6	6.5	0.0	0.9	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.3	0.0	0.0	0.1	2.0	5.5	16.5	0.0	0.0	3.5	0.2	2.0	3.4	0.0	3.5	0.0	1.2	0.2	1.9	0.0	0.0	1.0	0.0	6.9	3.8	0.0	1.5	0.0	0.0	0.0	1.5	0.8	0.2	0.3	0.1	0.0	0.9	0.2	0.2	0.4	0.4	0.5	0.3	0.1	1.8	0.3	0.0	0.2	0.7	0.2	1.1	2.5	6.9	1.1	0.8	0.6	2.1	0.3	1.7	2.2
